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Chapter one 
Introduction  
 
 
1.1. Fluorinated compounds in life 
 
Fluorinated compounds are used in many drugs, agrochemicals, and tools such as 
home electronics and analytical instruments that are used in daily life.  For example, 
“mouthwash liquid” used for the prevention of tooth decay and Teflon frying pans, 
which are used in cooking to prevent the food from burning easily, are familiar objects.  
Moreover, AlF3 is used as an additive in the electrolytic refining of aluminum; SF6 is 
used for the dry etching of insulators, semiconductor products, and liquid crystal panels.  
Furthermore, HF and F2 are used to enrich uranium by transforming uranium oxide into 
low-boiling uranium hexafluoride (UF6, boiling point 57 C).  Thus, fluorinated 
compounds are indispensable in our lives.  Most natural sources of fluorine are 
remarkably stable minerals such as fluorite (CaF2) and ice stone (Na3AlF6); however, 
they are difficult to use as fluorine source directly.  Therefore, they are transformed 
into other fluorine compounds with high chemical reactivity, e.g., fluorite is treated with 
concentrated hydrochloric acid to produce HF and is the most commercially available 
fluorine source.  Most fluorinated organic compounds are derived by chemical 
synthesis. Next, the characteristics and methods of preparation of fluorinated organic 
compounds are described.
1
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1.2. The feature of fluorinated organic compounds 
 
Fluorinated organic compounds are divided into “perfluorinated compounds” and 
“partially fluorinated compounds” as described below. 
 
1.2.1. Perfluorinated compounds 
Perfluorinated compounds are organic compounds in which all or most hydrogen (H) 
atoms are replaced by fluorine (F) atoms.  They have high bonding energies, low 
polarizabilities decreasing induced dipole express surface, spectrophotometric, and 
electrical characteristics.  These compounds are widely used as functional materials in 
electrical, chemical, medical, and other industries (Figure 1). 
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Sevoflurane: anesthesia  
Figure 1. Perfluorinated compounds 
 
(Characteristics) 
1) Resistance properties 
excellent heat resistance, remarkable chemical resistance, weather resistance, 
inflammation, and other physical traits 
2) Surface characteristics 
non-adhesive, water/oil repellency, scratch proof, and low frictional coefficient 
3) Light characteristics 
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low refractive indices and high opaqueness 
4) Electrical characteristics 
highly insulating, low electric inductance, and small dielectric loss 
 
1.2.2. Partially fluorinated compounds 
Partially fluorinated compounds are organic compounds in which some of the H 
atom(s) is(are) substituted by F atom(s).  The substitution(s) render(s) various effects, 
such as increasing polarity, mimicking biological systems, blocking metabolism, and 
increasing hydrophobicity.  These compounds are mainly used in medical and 
agrochemical fields. 
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Fluticasone: anti-inflammatory  
Figure 2. Partially fluorinated compounds 
 
(Characteristics) 
1) Polarity effect 
The high electronegativity of the fluorine atom (Figure 3) decreases the electron 
density of the carbon atom attached to it and surrounding atoms, thus preventing 
electrophilic attacks such as enzyme oxidation, resulting in enhanced pharmacological 
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effect, reduced side effects, and new bioactivity. 
 
Figure 3. Polarized C–F bond 
 
2) Mimic effect 
A fluorine atom is quite small in size, being only slightly larger than a hydrogen 
atom (van der Waals radius, F: 1.35Å, H: 1.10Å).  Thus, it is expected that a 
biologically active agent, in which a particular H atom is replaced by a fluorine atom, 
would circumvent the block in stereognostic recognition because of its polarity effect 
during in vivo absorption. 
3) Blocking effect 
 The C–F bond is more stable than C–H, C–Cl, and other bonds (Table 1); therefore, 
it is stable towards substitution, reduction, and oxidation reactions by enzymes in vivo.  
Therefore, metabolic degradation of the site around the C–F bond is suppressed. 
 
Table 1. Bond energies and bond lengths  
C–X bond C–F C–H C–Cl C–Br C–I 
Bond energy (kJ/mol) 485 411 327 285 213 
Bond lengths (pm) 135 109 177 194 214 
 
4) Increase hydrophobicity effect 
Fluorine atoms increase the lipophilicity of the compound and promote assimilation 
H
C
F
C
Electronegativity, H: 2.20, C: 2.55, F: 3.98


+
-
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and transportation in vivo; in particular, trifluoromethyl or perfluoroalkyl-substituted 
compounds exhibit higher lipophilicity than the precursors.  
 
 
1.3. Introduction of fluorine and fluorinated functional groups 
 
The degree of fluorination is difficult to control in reactions using F2 or HF because 
most simple fluorine sources are useful for introducing large amounts of fluorine atoms; 
therefore, most simple fluorine sources are ineffective for the preparation of partially 
fluorinated compounds.  Moreover, these methods need specialized equipment and 
techniques because of toxicity and causticity; therefore, synthesis methods using HF or 
F2 are ineffective in the preparation of partially fluorinated compounds.  Therefore, 
diverse methods have been developed for introducing fluorine and fluorine-containing 
functional groups at specific positions in organic compounds.
2
 
 
1.3.1. Introduction of trifluoromethyl and perfluoroalkyl groups 
Diverse trifluoromethylated arenes can be prepared by converting various functional 
groups to the trifluoromethyl group (Scheme 1).
3
  In addition to the classical methods, 
toxic SF4 is used to convert a trihalomethyl group to the corresponding trifluoromethyl 
group (Reaction type a).
3a–c
  New Deoxo-Fluor reagents have been developed for the 
conversion of a carboxylic acid group to the corresponding trifluoromethyl group 
(Reaction type b).
3d–g
  In particular, the studies on cross-coupling reactions using 
trifluoromethylating reagents derived from various chemical species (
+
CF3, 

CF3, 

CF3) 
with functional groups (halogen, B(OR)3, SnR3, H etc.) on arene have been increasing 
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over the past decade (Reaction type c–g).3h–p  
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Scheme 1. Strategy for the introduction of trifluoromethyl groups 
 
Scheme 2 shows the examples of recently published aryl trifluoromethylation 
methods.
4
  Gooβen and co-workers reported the Sandmeyer trifluoromethylation of 
arenediazonium tetrafluoroborates.  The diazonium salt is added to a Cu–CF3 species 
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preformed from CuSCN and Me3SiCF3 in the presence of Cs2CO3; this method allows 
the straightforward synthesis of trifluoromethylated arenes from the corresponding 
aromatic amines (equation 1).
4a
  The Greney group reported silver-catalyzed 
trifluoromethylation under mild conditions at room temperature in which the 
trifluoromethyl radical species (

CF3), generated by the reaction of Me3SiCF3 with 
PhI(OAc)2 and AgF, reacts with arenes (equation 2).
4b
  The Yu group reported the 
Pd-catalyzed ortho-C–H trifluoromethylation of benzylamines, in which additives, such 
as H2O and Ag2O, were found to be crucial for obtaining good yields (equation 3).
4c
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Scheme 2. Recently reported aryl trifluoromethylation 
 
The introduction of a trifluoromethyl group to an sp
3
-carbon atom, such as an allylic 
position, is also an area of active research.
5
  Recently, the Altman group reported 
 8 
unique allylic trifluoromethylation from allyl bromodifluoroacetates.  This reaction 
proposes Cu–CF3, generated from the CuI/NaO2CCF2Br/KF system, as the active 
species in the reaction (Scheme 3).
5a
 
 
O CF2Br
O
R
CF3R
cat. CuI, DMEDA
NaO2CCF2Br
KF, DMF, 50℃  
Scheme 3. Recently reported allylic trifluoromethylation 
 
Not only the conversion of different functional groups to trifluoromethyl groups, but 
also the transformation of different structures has attracted interest.
6
  Recently, the 
Sodeoka group reported N-migratory oxy- and amino-trifluoromethylation of allylamine 
derivatives using the Cu(I)/Togni reagent system (Scheme 4).
6a 
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Scheme 4. Synthesis of β-trifluoromethyl amines 
 
On the other hand, the Studer group reported the synthesis of 6-trifluoromethylated 
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phenanthridines starting from readily prepared isonitriles, in the absence of a transition 
metal catalyst.  In addition, this method can also be applied to the synthesis of 
perfluoroalkylated phenanthridines (Scheme 5).
6b
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Scheme 5. Synthesis of β-trifluoromethyl amines 
 
Chemical building blocks are effective for the synthesis of trifluoromethylated 
compounds,
7
 e.g., β-CF3-vinylsulfonium salt recently developed by our group is useful 
to introduce a trifluoromethyl group in three-carbon homologation reactions (Scheme 
6).
7a–e
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Scheme 6. Applications of β-CF3-vinylsulfonium salt 
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1.3.1. Introduction of a fluorine atom  
In the recent years, traditional metal-catalyzed fluorination reactions have been 
actively studied, particularly the reductive elimination of Ar-[M]-F species for aryl 
fluorination has been proven to occur through Pd(0)/Pd(II), Pd(II)/Pd(IV), or 
Cu(I)/Cu(III) catalytic cycles.
8
  Recently, the Buchwald group reported the 
Pd-catalyzed fluorination of aryl triflates.  They developed a new Pd catalyst based on 
a bulky biaryl phosphine ligand that allows the introduction of fluorine atoms into the 
triflate derivatives of various naturally occurring phenols (Scheme 7).
8a
 
 
 
Scheme 7. Pd-catalyzed fluorination of aryl triflates 
 
On the other hand, new Cu-catalyzed nucleophilic fluorinations have been recently 
reported (Scheme 8).
8b–e
  The Daugulis group reported the direct auxiliary-assisted 
fluorination of β-sp2 C–H bonds of benzoic acid derivatives; selective mono- or 
difluorination could be achieved by simply changing the reaction conditions (equations 
1, 2).
8b
  The Sanford group reported the fluorination of unsymmetrical diaryliodonium 
salts with KF.  They conduced density functional theory (DFT) calculations on the 
Cu(OTf)2 catalyzed fluorination of [Ph2I]BF4 with F

 ions to establish the Cu(I)/Cu(II) 
catalytic cycle (equation 3).
8c
  They also reported the fluorination of aryl 
OTf
R
F
R
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80-130℃
Pd
P
iPr
iPr
iPr
AdAd
Pd
P
iPr
iPr
iPr
Ad Ad
MeO
MeO
OMe
OMe
Pd catalyst
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trifluoroborates with potassium fluoride, mediated by an excess amount of Cu(OTf)2 
(equation 4).
8d
  The Liu group reported the Cu-catalyzed fluorination of allylic halides.  
This reaction allows the regioselective transformation of internal allylic bromides and 
chlorides to fluorine using Et3N3HF as the fluorine source.  For the C–F bond 
formation step in this reaction, a mechanism was proposed involving both the direct 
reductive elimination of allyl-[Cu(III)]-F intermediate and SN2-type nucleophilic attack 
of the allyl/Cu(III) complex from F

, which could not be differentiated at this stage 
(equation 5).
8e
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F
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Scheme 8. Cu-catalyzed fluorination reactions 
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Recently, the Litter group reported Pd(III) catalyzed fluorination of arylboronic acid 
derivatives using Selectfluor as the fluorine source.  They isolated and characterized 
the Pd(III) intermediate and proposed the single-electron transfer (SET) mechanism 
involving an unusual Pd(III) intermediate (Scheme 9).
9
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Scheme 9. Pd-catalyzed fluorination reactions 
 
The Groves group reported the Mn-catalyzed benzylic C–H fluorination that allows the 
formation of benzylic fluorides directly from C–H bonds using simple and easily 
handled nucleophilic fluoride reagents, Et3N3HF.
10 
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Scheme 10. Mn-catalyzed fluorination reactions 
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 Deoxyfluorination is effective for introducing one or more fluorine atoms into organic 
compounds.
11
  However, the current deoxyfluorination methods are commonly 
characterized by limited functional group tolerance, side reactions such as elimination, 
and instability or explosion of the reagents upon heating.  Recently, the Ritter group 
reported the late-stage deoxyfluorination of alcohols using the Deoxo-Fluor reagent, 
PhenoFluor, to solve these problems.  PhenoFluor is a crystalline, non-explosive solid, 
and is commercially available.
11a
 
 
OH
R
R2
R1
F
R
R2
R1
N N
F F
iPr iPr
iPr iPr
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iPr2EtN, KF
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R, R1, R2 = H, alkyl  
Scheme 11. Deoxyfluorination using PhenoFluor 
 
The Hartwig group reported the fluorination of pyridines and diazine derivatives with 
AgF2.  This selective fluorination reaction allows the access to 2-fluoropyridines and 
related 2-fluoroazines, which are medicinally important compounds under mild reaction 
conditions (Scheme 12).
12
 
 
N
R
N
R
H F
+   AgF2
CH3CN, rt.
 
Scheme 12. Regioselective fluorination of pyridines with AgF2 
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Mono-fluorinated building blocks are usually effective for introducing fluorine to 
construct mono-fluorinated organic compounds.
13
  Recently, the Jubalut group 
reported the diastereoselective access to functionalized mono-fluorinated cyclopropanes 
using mono-fluorinated quaternary ammonium salts derived from ethyl 
bromofluoroacetate.
13a
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Scheme 13. Mono-fluorinated cyclopropanation reaction 
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Chapter two 
Mizoroki-Heck Reaction of 
(1-Fluorovinyl)methyldiphenylsilane with Aryl Iodides 
 
 
2.1. Introduction 
 
Introduction of an aromatic ring to fluorinated olefins is an important task in 
organofluorine chemistry.  It is well-accepted that the Mizoroki-Heck reaction has 
proven to be a useful method for the arylation of general olefins in organic synthesis.
1  
 
A wide range of olefins containing various substituents can participate in the reaction,
2
 
however there are very few reports concerning the use of fluoroolefins.
3
  In addition, 
the Mizoroki-Heck reaction of silylated olefins are considered to be difficult because of 
its tendency toward elimination of the silyl moiety instead of hydrogen.
4 
 To the best 
my knowledge, there exist no reports concerning the use of silylated fluoroolefins for 
this reaction.  Recently, much effort has been performed to add the fluorine to organic 
molecules owing to its remarkable effects on their structure, stability, reactivity, and 
biological activity.
5 
 The stereoselective synthesis of fluoroolefins having a functional 
group also remains one of the challenging objectives.  Our group have reported a facile 
synthesis of (1-fluorovinyl)methyldiphenylsilane and its application for the construction 
of a wide range of fluorovinyl compounds.
6,7
  From alternative synthetic point of view, 
the silane should be a promising candidate for the Mizoroki-Heck reaction.  The author 
describes here the first example of the Mizoroki-Heck reaction of silylated fluoroolefin 
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and a synthetic utilization of the resulting coupling products to transform the 
corresponding cis-β-fluorostyrene derivative. 
 
 
2.2. Result and discussion 
 
The author started to examine the Mizoroki-Heck reaction by using 
(1-fluorovinyl)methyldiphenylsilane 1 and 4’-iodoacetophenone 2a as a model 
compound in order to explore the viability.  The author found, in the early experiment, 
that the reaction gave the desired product 3a albeit in 25 % yield and with low 
stereoselectivity (E/Z = 60/40) along with 1 and some byproduct in the presence of 10 
mol % of Pd(OAc)2 and Ag2CO3 (3 equiv.) in DMF at room temperature for 2 h.
8
  In 
order for the complete consumption of the unreacted 1, the longer reaction times caused 
3a to decompose and decrease the yield.  The author also noticed that when the 
reaction was conducted at an elevated temperature (50 ℃ ), the reaction was 
complicated to afford none of 3a.  These hopeless observations forced me to continue 
examinations of a variety of reaction factors such as Palladium catalyst, a base, a 
solvent, temperature, and additives. 
The author showed some results of the reaction conditions in Table 1.  As seen to 
this Table 1, the author determined that the entry 13 was the optimal reaction conditions.  
The reaction proceeded to afford the desired product 3a in 72 % yield with excellent 
stereoselectivity (E/Z = 98/2).  The E/Z stereochemistry of the product 3a was assigned 
on the basis of the coupling constant of its 
1
H and 
19
F NMR.  The J value of 50.3 Hz 
between the fluorine atom and vinyl proton supported the corresponding 
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E-configuration.  The embedded aryl group is located at the trans position toward the 
bulky methyldiphenylsilyl group.  This trans relationship between the aryl and the silyl 
group is similar to that of the aryl and acyl groups in the Mizoroki-Heck reaction using 
3-fluoro-3-buten-2-one.
3d
  The plausible reaction mechanism for the excellent 
E-stereoselectivity should be ascribed to the contribution of the stable conformer A 
prior to the required syn elimination (Scheme 1). 
 
H
HAr
PdLn
SiPh2MeF
A B
H
ArH
PdLn
SiPh2MeF
E-isomer Z-isomer  
Scheme 1. Stability of palladium intermediates 
 
It is noteworthy that the reaction system containing Pd(OAc)2 (10 mol %) and Ag2CO3 
(3 equiv.) in dioxane at 90 ℃ was essential for the successful reaction.  Except for 
these conditions, none of other combinations using other bases, Pd sources, and 
different solvents failed to improve the yield (entries 2–10).  When the author 
conducted the reaction in the presence of the lower loading of Ag2CO3 (1–2 equiv.) and 
Pd(OAc)2 (5 mol %), the lower yields (entries14–16) were observed.  Although the use 
of MS4Å plays an important role in this reaction, its contribution is not clear at present.  
The author guessed that it might remove a trace amount of water probably generated 
from decomposition of H2CO3 resulted from Ag2CO3 in the reaction mixture. 
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Table 1. Optimization of reaction conditions for the Mizoroki-Heck reaction of 1
a
 
SiPh2Me
F
Ac I+
SiPh2Me
F
Ac
1 2a 3a
cat. Pd
base, additive
solvent, temp.
 
entry 
 
Pd 
(10 mol %) 
base 
(equiv.) 
solvent 
 
temp. 
(℃)  
time 
(h)  
additive 
 
yield
b
  
(%)  
E/Z
c
 
 
1 Pd(OAc)2 Ag2CO3 (3) DMF rt  2  none 25  60/40 
2  Pd(OAc)2 NaOAc (3) DMF 50  12  none trace  - 
3  Pd(OAc)2 TEA (3) DMF 100  12  none 0  - 
4  PdCl2 Ag2CO3 (3) DMF 50  10  none 0  - 
5  Pd(PPh3)4 Ag2CO3 (3) DMF 50  12  none 0  - 
6  Pd(OAc)2 Ag2CO3 (3) DMSO 100  12  none 0  - 
7  Pd(OAc)2 Ag2CO3 (3) NMP 100  12  none 0  - 
8  Pd(OAc)2 Ag2CO3 (3) DMI 100  10  none 0  - 
9 Pd(OAc)2 Ag2CO3 (3) MeCN 50  12  none 0  - 
10 Pd(OAc)2 Ag2CO3 (3) THF 60  12  none 0  - 
11 Pd(OAc)2 Ag2CO3 (3) dioxane 90  12  none 40  98/2 
12 Pd(OAc)2 Ag2CO3 (4) dioxane 90  10  MS4Å 72  98/2 
13 Pd(OAc)2 Ag2CO3 (3) dioxane 90  12  MS4Å 72  98/2 
14 Pd(OAc)2 Ag2CO3 (2) dioxane 90  12  MS4Å 62  98/2 
15 Pd(OAc)2 Ag2CO3 (1) dioxane 90  12  MS4Å 48  98/2 
16 Pd(OAc)2
d
 Ag2CO3 (3) dioxane 90  20  MS4Å 60  97/3 
17 Pd(OAc)2 Ag2CO3 (3) dioxane 70  10  MS4Å 56  99/1 
a
 The reaction of 1 (1.0 equiv.) with 2 (2.0 equiv.) was carried out.  
b
 Isolated yield.   
c 
Determined by GC-MS.  
d
 Pd(OAc)2 (5 mol %) was used.                 . 
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With the optimized reaction conditions in hand, the author examined the substrate 
scope.  The results are shown in Table 2.  The substrate scope was wide and the 
position of the aromatic ring as well as the nature of the substituents did not essentially 
affect the reaction.  The chemical yield of the reaction was generally good to high.  
The author found that the stereoselectivity of the reaction was excellent except for 3d.
9  
A wide range of functional groups such as alkyls, esters, ethers, a nitro, a cyano, and 
halogens were tolerated (entries 1–14).  Unfortunately, no heteroaryl iodides such as 
2-iodothiophene and 2-iodopyridine participated in the reaction (entries 15, 16).  In 
addition, 4’-bromoacetophenone as a more available and less expensive aryl bromide 
was found to be unsuitable for the reaction (entry 17).  In these cases, no reactions 
occurred and both of the starting materials were almost recovered intact. 
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Table 2. Substrate scope of aryl iodides
a  
SiPh2Me
F
+
SiPh2Me
FAr
1 2 3
Pd(OAc)2 (10 mol%)
Ag2CO3 (3.0 equiv.)
1,4-dioxane
MS4Å, 90℃
ArI
 
entry 
 
ArI 
 
3 
 
time     
(h)     
yield
b
     
(%)     
E/Z
c
 
 
1      4-AcC6H4I 3a  4     72     98/2 
2      4-EtO(=O)C6H4I 3b 2     63     99/1 
3      4-O2NC6H4I 3c 4     81     96/4 
4      4-NCC6H4I 3d 3     63     93/7 
5      4-CF3C6H4I 3e 5     77     97/3 
6      4-MeOC6H4I 3f 5     61     97/3 
7      2-FC6H4I 3g 19     70     98/2 
8      2-ClC6H4I 3h 4     88     97/3 
9      2-BrC6H4I 3i 3     85     98/2 
10      2-MeO(=O)C6H4I 3j 2     60     98/2 
11      2-EtC6H4I 3k 6     65     98/2 
12      3-MeOC6H4I 3l 4     78     97/3 
13      2,4-MeC6H4I 3m 18     67     98/2 
14      C6H4I 3n 6     72     96/4 
15      thiophene-2-I 3o   24     NRd     - 
16      pyridine-2-I 3p 24     NRd     - 
17      4-AcC6H4Br
e
 3q 24     NR
d
     - 
a
 The reaction of 1 (1.0 equiv.) with 2 (2.0 equiv.) was carried out.  
b
 Isolated yield.  
c
 Determined by GC-MS.  
d
 No reaction.  
e
 Aryl bromide was used.                  . 
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The author briefly attempted to modify the resulting product 3f in order to illustrate the 
synthetic scope of this methodology (Scheme 2).  The author selected the 
stereoselective synthesis of the corresponding cis-β-fluorostyrene 4f.  Because if this 
transformation proceeds with complete retention of the configuration of the double bond, 
an overall reaction should afford a new stereoselective synthesis of cis-β-fluorostyrene 
derivatives.
10
  Fortunately, the fluoride ion-assisted desilylation-protonation cleanly 
proceeded giving the desired product 4f; however, the author encountered that the 
purification of 4f from the crude reaction mixture on silica gel column chromatography 
proved to be more difficult due to their very close Rf values between 4f and impurities. 
After many attempts, the transformation was accomplished by treatment with potassium 
tert-butoxide (tBuOK) in DMSO.  The sequential purification of 4f on silica gel 
column chromatography was conducted to give the desired 4f in 99 % yield (Scheme 2). 
 
SiPh2Me
F
MeO
F
MeO
3f 4f (99%)
tBuOK (1.5 equiv.)
DMSO, r.t., 1h
 
Scheme 2. Transformation of 3f to the corresponding cis-fluoroolefin 4f 
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2.3. Conclusion 
 
In summary, the author has firstly developed the Mizoroki-Heck reaction of silylated 
fluoroolefin 1 with a wide range of aryl iodides in good to high yields.  The 
desilylation-protonation reaction of the product cleanly proceeded affording the desired 
β-fluorostyrene derivative with very high stereoselectivity.  This method should offer 
additional opportunities to be of help in fluoroorganic synthesis. 
 
 
2.4. Experimental 
 
2.4.1. General information  
1
H, 
13
C, and 
19
F NMR spectra were measured in CDCl3 solutions, unless otherwise 
stated.  Chemical shifts were given by δ relative to that of an internal Me4Si (TMS) for 
1
H NMR and 
13
C NMR spectra.  On the other hand, chemical shifts were given by δ 
relative to that of CFCl3 for 
19
F NMR spectra using an internal CF3C6H5 
(benzotrifluoride) or C6F6.  Infrared (IR) spectra are reported in cm
-1
.  Melting points 
are uncorrected.  
 
2.4.2. Preparation of 3a  
A 25 mL two-necked glass flask attached with a magnetic stir bar, a stopcock, and a 
three-way stopcock was successively charged with (1-fluorovinyl)methyldiphenylsilane 
1 (47.5 mg, 0.196 mmol, 1.0 equiv.), 4’-iodoacetophenone 2a (96.4 mg, 0.391 mmol, 
2.0 equiv.), Ag2CO3 (162.1 mg, 0.606 mmol, 3.0 equiv.), Pd(OAc)2 (4.4 mg, 0.02 mmol, 
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10 mol %), and powdered MS4Å (ca. 160 mg) in 1,4-dioxane (1 mL).  The whole 
resulting reaction mixture was generally heated at 90 ℃.  When the reaction was 
completed for 4 h as monitored by GC-MS, the reaction mixture was cooled to room 
temperature.  The cooled mixture was filtered off through celite pad with ether.  After 
to the filtrate was added water, the organic layer was carefully separated.  An 
additional extraction with hexane/EtOAc = 3/1 was repeated twice.  The combined 
organic solution was dried over Na2SO4 and concentrated in vacuo.  The resulting oily 
residue was first purified by column chromatography (silica gel, hexane/EtOAc = 10/1) 
to give the desired compound 3a along with a small amount of impurities.  The 
resulting oily residue was again purified by bulb-to-bulb distillation to give 3a as a pale 
yellow solid (50.9 mg, 72 %). 
 
2.4.3. Preparation of 4f  
A 25 mL two-neck flask attached with a magnetic stir bar, a stopcock, and a three-way 
stopcock was successively charged with 3f (72.9 mg, 0.209 mmol, 1.0 equiv.), tBuOK 
(34.7 mg, 0.309 mmol, 1.5 equiv.), and DMSO (1.0 mL) at room temperature. After the 
reaction was stirred for 1 h, the reaction mixture was quenched with water. After 
separation of the organic layer, additional extraction with hexane/EtOAc was repeated 
twice.  The combined organic solution was dried over Na2SO4 and concentrated in 
vacuo.  The residual oil was purified by silica gel chromatography (hexane/ether = 
100/1) to give 4f as a colorless oil (31.6 mg, 99 %) 
 
2.4.4. Data of products (3a–3n, 4f) 
(E)-[1-Fluoro-2-(4’-acetylphenyl)vinyl]methyldiphenylsilane (3a) 
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Pale yellow solid; yield 72 %; mp: 92.1–93.5 ℃; IR (KBr) 3069, 1680, 1601, 1489, 
1355, 1266, 1184, 1115, 1044, 796, 736, 701 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.90 
(d, J = 8.4 Hz, 2H) 7.66–7.60 (m, 6H), 7.49–7.36 (m, 6H), 5.97 (d, J = 50.3 Hz, 1H), 
2.59 (s, 3H), 0.81 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 197.5, 169.4 (d, J = 295.8 Hz), 
137.8 (d, J = 2.5 Hz), 135.9 (d, J = 2.5 Hz), 135.0, 133.0 (d, J = 1.2Hz), 130.2, 129.3 (d, 
J = 8.1 Hz), 128.2, 128.5, 122.4 (d, J = 1.9 Hz), 26.6, –5.0 (d, J = 1.2 Hz); 19F NMR 
(CDCl3, 283 MHz) δ –108.6 (d, J = 50.3 Hz); GC-MS (EI, m/z, 70 eV) 360 (3, M
+
), 344 
(7), 281 (8), 266 (14), 201 (59), 181 (22), 139 (100), 105 (19), 91 (44); Anal. Calcd. for 
C23H21FOSi: C, 76.63; H, 5.87. Found: C, 76.64; H, 5.89. 
 
(E)-[1-Fluoro-2-[4’-(ethoxycarbonyl)phenyl]vinyl]methyldiphenylsilane (3b) 
White solid; yield 63 %; mp: 71.1–72.7 ℃; IR (KBr) 3066, 2974, 1708, 1606, 1427, 
1286, 1180, 1109, 1051, 1017, 784, 734, 699 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.98 
(d, J = 8.3 Hz, 2H), 7.68–7.57 (m, 6H), 7.51–7.37 (m, 6H), 5.97 (d, J = 50.7 Hz, 1H), 
4.37 (q, J = 7.16 Hz, 2H), 1.39 (t, J = 7.16 Hz, 3H), 0.81 (s, 3H); 
13
C NMR (CDCl3, 75 
MHz) δ 169.1 (d, J = 295.2 Hz), 166.3, 137.5 (d, J = 2.5 Hz), 135.0, 133.0, 130.2, 129.6, 
129.3 (d, J = 2.5 Hz), 129.1 (d, J = 8.1 Hz), 122.5 (d, J = 1.8 Hz), 60.9, 14.3, –5.0; 19F 
NMR (CDCl3, 283 MHz) δ –109.2 (d, J = 50.7 Hz); GC-MS (EI, m/z, 70 eV) 348 (21), 
286 (5), 255 (26), 231 (60), 201 (89), 169 (25), 139 (100), 105 (30), 91 (81), 77 (17); 
Anal. Calcd. for C24H23FO2Si: C, 73.81; H, 5.94. Found: C, 74.00; H, 6.02. 
 
(E)-[1-Fluoro-2-[4’-(nitrophenyl)vinyl]methyldiphenylsilane (3c) 
Pale yellow solid; yield 81 %; mp: 87.9–89.0 ℃; IR (KBr) 3068, 1633, 1597, 1521, 
1428, 1342, 1116, 1108, 1058, 824, 795, 735, 674 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 
 28 
8.17 (d, J = 8.8 Hz, 2H), 7.68 (d, J = 8.8 Hz, 2H), 7.63 (dd, J = 7.7, 1.8 Hz, 4H), 
7.53–7.37 (m, 6H), 5.99 (d, J = 49.4 Hz, 1H), 0.82 (s, 3H); 13C NMR (CDCl3, 75 MHz) 
δ 171.0 (d, J = 299.0 Hz), 146.6 (d, J = 3.1 Hz), 139.5 (d, J = 3.1 Hz), 135.0, 132.5 (d, J 
= 1.2 Hz), 130.3, 129.8 (d, J = 8.7 Hz), 128.2, 123.7, 121.3 (d, J = 1.9 Hz), –5.0; 19F 
NMR (CDCl3, 283 MHz) δ –113.6 (d, J = 49.4 Hz); GC-MS (EI, m/z, 70 eV) 347 (5), 
286 (4), 255 (23), 231 (55), 201 (81), 178 (21), 165 (25), 139 (100), 105 (32), 91 (95); 
Anal. Calcd. for C21H18FNO2Si: C, 69.40; H, 4.99; N 3.85. Found: C, 69.33; H, 4.96; N, 
3.83. 
 
(E)-[1-Fluoro-2-(4’-cyanophenyl)vinyl]methyldiphenylsilane (3d) 
Pale yellow solid; yield 63 %; mp: 109.0–110.9 ℃; IR (KBr) 2229, 1588, 1505, 1488, 
1428, 1255, 1109, 1049, 835, 800, 783, 733, 700 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 
7.66–7.55 (m, 7H), 7.51–7.36 (m, 7H), 5.93 (d, J = 49.6 Hz, 1H), 0.81 (s, 3H); 13C 
NMR (CDCl3, 75 MHz) δ 170.4 (d, J = 297.7 Hz), 137.6 (d, J = 3.1 Hz), 135.0, 132.6, 
132.1, 130.3, 129.6 (d, J = 8.7 Hz), 128.2, 121.3 (d, J = 1.9 Hz), 118.8, 110.9 (d, J = 3.1 
Hz), –5.1; 19F NMR (CDCl3, 283 MHz) δ –107.0 (d, J = 49.6 Hz); GC-MS (EI, m/z, 70 
eV) 343 (2, M
+
), 280 (4), 265 (15), 250 (14), 227 (7), 201 (66), 179 (15), 139 (100), 105 
(19), 91 (47); HRMS (FAB, m/z) Calcd. for C22H19NFSi: 344.1295; Found: 344.1271.  
 
(E)-[1-Fluoro-2-[4’-(trifluoromethyl)phenyl]vinyl]methyldiphenylsilane (3e) 
Colorless oil; yield 77 %; IR (NaCl) 3071, 1617, 1489, 1430, 1326, 1168, 1115, 1068, 
829, 794, 728, 698, 671 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.68–7.52 (m, 7H), 
7.47–7.36 (m, 7H), 5.96 (d, J = 50.1 Hz, 1H), 0.81 (3H, s); 13C NMR (CDCl3, 75 MHz) 
δ 169.2 (d, J = 294.6 Hz), 136.6 (dq, J = 3.1, 1.3 Hz), 135.0, 133.1 (d, J = 1.9 Hz), 
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130.0, 129.6 (d, J = 2.5 Hz), 129.4 (d, J = 8.1 Hz), 128.2, 124.1 (q, J = 277.2 Hz), 125.3 
(q, J = 3.7 Hz), 122.0 (d, J = 1.3 Hz), –4.96; 19F NMR(CDCl3, 283 MHz) δ –109.5 (d, J 
= 50.1 Hz), –64.0; GC-MS (EI, m/z, 70 eV) 386 (1, M+), 308 (10), 293 (11), 246 (20), 
227 (55), 201 (92), 151 (55), 139 (100), 105 (41), 91 (76); Anal. Calcd. for C22H18F4Si: 
C, 68.37; H, 4.69. Found: C, 68.66; H, 4.74. 
 
(E)-[1-Fluoro-2-(4’-methoxyphenyl)vinyl]methyldiphenylsilane (3f) 
White solid; yield 61 %; mp: 47.1–49.0 ℃; IR (KBr) 3011, 1606, 1506, 1428, 1251, 
1180, 1117, 1044, 874, 829, 739, 701 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.63 (dd, J = 
7.7, 1.5 Hz, 4H), 7.15 (d, J = 8.8 Hz, 2H), 7.46–7.34 (m, 6H), 6.84 (d, J = 9.0 Hz, 2H),  
5.87 (d, J = 51.8 Hz, 1H), 3.80 (s, 3H), 0.77 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 
165.2 (d, J = 286.5 Hz), 159.1 (d, J = 3.1 Hz), 135.0, 133.7 (d, J = 1.2 Hz), 130.7 (d, J = 
8.1 Hz), 129.9, 128.0, 126.3 (d, J = 2.5 Hz), 123.0 (d, J = 1.3 Hz), 113.9, 55.2, –4.81 (d, 
J = 1.2 Hz); 
19
F NMR (CDCl3, 283 MHz) δ –117.3 (d, J = 51.8 Hz); GC-MS (EI, m/z, 
70 eV) 348 (19, M
+
), 286 (5), 255 (26), 231 (57), 201 (83), 178 (20), 165 (25), 139 
(100), 105 (29), 91 (79); Anal. Calcd. for C22H21FOSi: C, 75.82;H, 6.07. Found: C, 
75.82; H, 6.08. 
 
(E)-[1-Fluoro-2-[2’-(fluorophenyl)vinyl]methyldiphenylsilane (3g) 
Colorless oil; yield 70 %; IR (NaCl) 3071, 1579, 1482, 1429, 1231, 1117, 1100, 1054, 
793, 755, 727, 670 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 8.02–7.93 (m, 1H), 7.64 (dd, J 
= 7.5, 1.8 Hz, 4H), 7.78–7.47 (m, 6H), 7.25–7.17 (m, 1H), 7.15–7.06 (m, 1H) 7.04–6.98 
(m, 1H), 6.31 (d, J = 51.1 Hz, 1H), 0.80 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 168.5 
(dd, J = 293.3, 2.5 Hz), 159.3 (dd, J = 249.8, 1.2 Hz), 135.0, 133.2, 131.1 (dd, J = 13.7, 
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2.5 Hz), 130.1, 129.3 (dd, J = 8.7, 1.9 Hz), 128.1, 124.2 (d, J = 19.9 Hz), 121.1 (dd, J = 
11.9, 2.5 Hz), 115.1 (d, J = 21.1 Hz), 114.4 (dd, J = 6.8, 1.8 Hz), –4.9; 19F NMR 
(CDCl3, 283 MHz) δ –111.3 (dd, J = 51.1, 6.1 Hz, 1F), –117.6 (dt, J = 9.3, 6.1 Hz, 1F); 
GC-MS (EI, m/z, 70 eV) 336 (0.5, M
+
), 254 (49), 239 (28), 201 (86), 178 (59), 165 (28), 
152 (24), 139 (100), 105 (30), 91 (76); Anal. Calcd. for C21H18F2Si: C, 74.97; H, 5.39. 
Found: C, 75.13; H, 5.39. 
 
(E)-[1-Fluoro-2-(2’-chlorophenyl)vinyl]methyldiphenylsilane (3h) 
Colorless oil; yield 88 %; IR (NaCl) 3070, 1589, 1429, 1254, 1115, 1052, 794, 728, 698 
cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.96 (dd, J = 7.7, 1.3 Hz, 1H) 7.65 (dd, J = 7.3, 1.5 
Hz, 4H), 7.48–7.32 (m, 7H), 7.27–7.13 (m, 2H), 6.41 (d, J = 50.5 Hz, 1H), 0.81 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 168.2 (d, J = 294.6 Hz), 135.0, 133.2 (d, J = 1.2 Hz), 
132.7 (d, J = 1.2 Hz), 131.3 (d, J = 12.4Hz), 131.1 (d, J = 2.5Hz), 130.1, 129.4, 128.8 (d, 
J = 1.2 Hz), 128.1, 126.7, 119.1 (d, J = 2.5 Hz), –4.93 (d, J = 1.3 Hz); 19F NMR (CDCl3, 
283 MHz) δ –113.3 (d, J = 50.5 Hz); GC-MS (EI, m/z, 70 eV) 352 (0.1, M+), 254 (21), 
239 (5), 223 (5), 212 (10), 201 (53), 178 (32), 139 (100), 105 (19), 91 (50); Anal. Calcd. 
for C21H18ClFSi: C, 71.47; H, 5.14. Found: C, 71.56; H, 5.13. 
 
(E)-[1-Fluoro-2-(2’-bromophenyl)vinyl]methyldiphenylsilane (3i) 
Colorless oil; yield 85 %; IR (NaCl) 3070, 1589, 1461, 1429, 1254, 1115, 1057, 1045, 
793, 728, 698 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ, 7.93 (dd, J = 7.7, 1.7 Hz, 1H) 7.65 
(dd, J = 7.7, 1.8 Hz, 4H), 7.55 (dd, J = 8.1, 1.3 Hz, 1H), 7.48–7.36 (m, 6H), 7.32–7.23 
(m, 1H), 7.14–7.04 (m, 1H), 6.37 (d, J = 50.1 Hz, 1H), 0.81 (3H, s); 13C NMR (CDCl3, 
75 MHz) δ 167.9 (d, J = 294.6 Hz), 135.0, 133.1 (d, J = 1.2 Hz), 132.73 (d, J = 12.4 Hz), 
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132.67, 131.4 (d, J = 20.5 Hz), 130.1, 129.0 (d, J = 1.3 Hz), 128.1, 127.3, 123.4 (d, J = 
1.2 Hz), 121.9 (d, J = 3.2 Hz), –4.98 (d, J = 1.2 Hz); 19F NMR (CDCl3, 283 MHz) δ 
–114.0 (d, J = 50.1 Hz); GC-MS (EI, m/z, 70 eV) 397 (0.8, M+), 317 (7), 302 (10), 255 
(28), 239 (44), 223 (9), 201 (98), 178 (71), 139 (100), 91 (68); Anal. Calcd. for 
C21H18BrFSi: C, 63.48; H, 4.57. Found: C, 63.71; H, 4.58. 
 
(E)-[1-Fluoro-2-[2’-(methoxycarbonyl)phenyl]vinyl]methyldiphenylsilane (3j) 
Colorless oil; yield 60 %; IR (NaCl) 1721, 1598, 1429, 1080, 794, 728 cm
-1
; 
1
H NMR 
(CDCl3, 300 MHz) δ 7.92–7.82 (m, 1H), 7.66 (dd, J = 1.8, 7.5 Hz, 4H), 7.51–7.35 (m, 
8H), 7.35–7.25 (m, 1H), 6.77 (d, J = 50.3 Hz, 1H), 3.75 (s, 3H), 0.81 (s, 3H); 13C NMR 
(CDCl3, 75MHz) δ 167.8, 166.6 (d, J = 292.1 Hz), 135.1, 133.4 (d, J = 1.3 Hz), 133.3 (d, 
J = 4.4 Hz), 131.7, 131.3 (d, J = 9.4 Hz), 130.0, 129.0 (d, J = 1.3 Hz), 128.1, 127.3, 
123.4 (d, J = 1.2 Hz), 121.6 (d, J = 3.2 Hz), 51.9, –5.0 (d, J = 1.2 Hz); 19F NMR (CDCl3, 
283 MHz) δ –116.4 (d, J = 50.3 Hz); GC-MS (EI, m/z, 70 eV) 376 (0.2, M+), 360 (4), 
299 (37), 197 (64), 179 (100), 151 (37), 139 (34), 129 (41), 101 (25), 91 (42); Anal. 
Calcd. for C23H21O2FSi: C, 73.37; H, 5.62. Found: C, 73.66; H, 5.76. 
 
(E)-[1-Fluoro-2-(2’-ethylphenyl)vinyl]methyldiphenylsilane (3k) 
Colorless solid; yield 65 %; mp: 46.0–48.0 ℃; IR (KBr) 3068, 2965, 1588, 1476, 1428, 
1250, 1118, 1044, 757, 736, 700, 670 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.84–7.75 (m, 
1H), 7.64 (dd, J = 7.7, 2.0 Hz, 4H), 7.47–7.36 (m, 7H), 7.22–7.11 (m, 2H), 6.12 (d, J = 
50.6 Hz, 1H), 2.51 (q, J = 7.52 Hz, 2H), 1.08 (t, J = 7.52 Hz, 3H), 0.80 (s, 3H); 
13
C 
NMR (CDCl3, 75 MHz) δ 166.4 (d, J = 290.2 Hz), 141.8, 135.0, 133.6 (d, J = 1.9 Hz), 
130.9 (d, J = 2.5 Hz), 130.2 (d, J = 10.0 Hz), 130.0, 128.6, 128.1, 128.0 (d, J = 1.2 Hz), 
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125.9, 121.0 (d, J = 1.3 Hz), 26.9, 15.0, –4.9; 19F NMR (CDCl3, 283 MHz) δ –116.5 (d, 
J = 50.6 Hz); GC-MS (EI, m/z, 70 eV) 347 (11, M
+
), 346 (35), 253 (6), 206 (23), 201 
(61), 197 (48), 191 (12), 139 (100), 129 (26), 91 (22); Anal. Calcd. for C23H23FSi: C, 
79.72; H, 6.69. Found: C, 79.71; H, 6.67. 
 
(E)-[1-Fluoro-2-(3’-methoxyphenyl)vinyl]methyldiphenylsilane (3l) 
Colorless oil; yield 78 %; IR (NaCl) 1599, 1428, 1256, 1115, 1050, 792, 670, 727, 697 
cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.63 (dd, J = 1,8, 7.7 Hz, 4H), 7.47–7.35 (m, 6H), 
7.27–7.07 (m, 3H), 6.98 (dd, J = 8.1, 2.6 Hz, 1H), 5.91 (d, J = 51.0 Hz, 1H), 3.79 (s, 
3H), 0.79 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 167.1 (d, J = 291.4 Hz), 159.5, 135.0, 
134.5 (d, J = 2.4 Hz), 133.4 (d, J = 1.3 Hz), 130.0, 129.3, 128.1, 123.3 (d, J = 1.9 Hz), 
121.9 (d, J = 6.9 Hz), 114.3 (d, J = 8.1 Hz), 114.0 (d, J = 1.9 Hz), 55.2, –4.9 (d, J = 1.2 
Hz); 
19
F NMR (CDCl3, 283 MHz) δ –112.6 (d, J = 51.0 Hz); GC-MS (EI, m/z, 70 eV) 
348 (8, M
+
), 332 (4), 269 (9), 254 (41), 201 (73), 178 (37), 165 (18), 139 (100), 105 
(26), 91 (70); Anal. Calcd. for C22H21FOSi: C, 75.82; H, 6.07. Found: C, 75.78; H, 6.08. 
 
(E)-[1-Fluoro-2-(2’,4’-dimethylphenyl)vinyl]methyldiphenylsilane (3m) 
Colorless oil; yield 67 %; IR (NaCl) 3070, 1613, 1589, 1429, 1253, 1116, 1053, 793, 
728, 698 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.69 (d, J = 7.9 Hz, 1H), 7.64 (dd, J = 7.5, 
1.7 Hz, 4H), 7.45–7.34 (m, 6H), 7.01–6.94 (m, 2H), 6.07 (d, J = 49.2 Hz, 1H), 2.28 (s, 
3H), 2.15 (s, 3H), 0.70 (s, 3H); 
13
C NMR (CDCl3, 75 MHz) δ 165.8 (d, J = 289.0 Hz), 
137.5 (d, J = 1.2 Hz), 135.5, 135.0, 133.7, 130.8, 130.0, 129.8, 128,4 (d, J = 1.8 Hz), 
128.0, 126.6, 121.0, 21.1, 19.9, –4.9 (d, J = 1.2 Hz); 19F NMR (CDCl3, 283 MHz) δ 
–116.4 (d, J = 49.2 Hz); GC-MS (EI, m/z, 70 eV) 347 (3, M+), 253 (14), 229 (7), 201 
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(91), 181 (16), 165 (11), 152 (7), 139 (100), 105 (38), 91 (68); Anal. Calcd. for 
C23H23FSi: C, 79.72; H, 6.69. Found: C, 79.74; H, 6.71. 
 
(E)-(1-Fluoro-2-phenylvinyl)methyldiphenylsilane (3n) 
Colorless oil; yield 72 %; IR (NaCl) 3070, 3051, 3025, 1589, 1447, 1115, 1049, 793, 
727, 695 cm
-1
; 
1
H NMR (CDCl3, 300 MHz) δ 7.67–7.59 (m, 7H), 7.58–7.51 (m, 2H), 
7.47–7.35 (m, 7H), 5.96 (d, J = 50.1 Hz, 1H), 0.80 (s 3H); 13C NMR (CDCl3, 75 MHz) 
δ 166.9 (d, J = 290.2 Hz), 135.0, 133.4 (d, J = 1.3 Hz), 133.3 (d, J = 2.5 Hz), 130.0, 
129.3 (d, J = 7.4 Hz), 128.4, 128.1, 127.8 (d, J = 2.5 Hz), 123.4 (d, J = 1.9 Hz), –4.9 (d, 
J = 1.3 Hz); 
19
F NMR (CDCl3, 283 MHz) δ –106.1 (d, J = 50.1 Hz); GC-MS (EI, m/z, 
70 eV) 318 (2, M
+
), 302 (5), 255 (11), 239 (31), 225 (39), 201 (97), 178 (84), 139 (100), 
105 (30), 91 (56); HRMS (FAB, m/z) Calcd. for C21H19FSi: 318.1240; Found: 318.1209.  
 
(Z)-1-Fluoro-2-(4’-methoxyphenyl)ethene (4f)10a 
Colorless oil;
 
yield 99 %; 
1
H NMR (CDCl3, 300 MHz) δ 7.45 (d, J = 8.8 Hz, 2H), 6.87 
(d, J = 8.8 Hz, 2H), 6.59 (dd, J = 82.9, 5.3 Hz, 1H), 5.54 (dd, J = 35.1, 5.3 Hz, 1H), 
3.81 (s, 3H). 
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Chapter three 
Synthesis of 2-Aryl-3-fluoro-5-silylthiophenes via  
Cascade Reactive Sequence 
 
 
3.1. Introduction 
 
Organofluorine chemistry has recently made great progress in medicinal and 
agricultural fields.  On the other hand, heteroaromatic chemistry has a long unique 
history in the similar fields.  The thiophene nucleus was representative for a 
component of several classes of bioactive natural compounds and functional materials.
1
  
Therefore, a easy synthesis for fluorinated thiophenes still remains a challenging task.  
By literature survey, there are only a few procedures for the preparation of fluorinated 
thiophenes despite the fact that fluoro substituents are powerful modifiers of chemical 
and biological properties of organic molecules as reported in many pharmaceuticals and 
agrochemicals.
2
  There are a lot of methods for the synthesis of fluorinated thiophenes 
based on an application of the substitution reactions of fluorine on the thiophene ring.
3 
 
In contrast to these traditional methods, few are alternative synthetic strategy for the 
regioselective synthesis of fluorinated thiophenes via cyclization process.  To the best 
of my knowledge, only three groups have reported this methodology for the synthesis of 
substituted fluorothiophenes.
4
  Our group has been interested in the building block 
strategy for introduction of fluorine(s) into organic molecules.
5
  To expand the 
synthetic possibility of 2-bromo-3,3,3-trifluoropropene 1 as a starting material, the 
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author focused on its SN2’-type reaction.  The author found that the similar SN2’-type 
reactions have already been reported by several groups in the literature.
6
  Among them, 
there was only one example of using 2-bromo-3,3,3-trifluoropropene.
7
  The author 
describes here the first efficient SN2’-type reactions of 1 with various thiolates, giving 
highly selective 2-bromo-3,3-difluoroallyl sulfides 2.  In addition, the author explained 
the step-wise synthesis of 2-aryl-3-fluoro-5-silylthiophenes 10 in high yield in the latter 
part.  
 
 
3.2. Results and discussion 
 
The author initially investigated a SN2’-type reaction of 1 and thiophenol under various 
reaction conditions (Table 1).  According to the previous reported procedure, when the 
reaction of 1 (3.0 equiv.) and thiophenol (1.0 equiv.) was carried out in THF in the 
presence of NaH (1.3 equiv.), the desired SN2’-type product 2a was obtained along with 
an unexpected structural isomer 3a, with a ratio of 2a/3a = 80/20 in 57 % combined 
yield.  Unfortunately, the author figured out that this mixture was unable to be 
separated into its components.  The author determined the structures of 2a and 3a on 
the basis of their 
1
H and 
19
F NMR.  The author considered that the product 3a was 
probably formed via an excessive SN2’-type reaction of 2a with thiophenoxide.  With 
this consideration in mind, the author continued to determine the optimal reaction 
conditions.  As a result, when this reaction was performed in 1,4-dioxane for 6 h, the 
selectivity was improved to afford the products with a ratio of 2a/3a = 93/7 in 73 % 
combined yield.  Increasing or decreasing the amount of 1 influenced the product 
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selectivity to some extent.  The author observed that lowering the amount of 1 to 1.0 
equivalents resulted in the slightly lower selectivity, whereas increasing that of 1 to 5.0 
equivalents resulted in the slightly higher selectivity.  Interestingly, other tested 
solvents retarded the formation of the desired product 2a. 
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Table 1. Reaction of 1 and thiophenol under various conditions 
F3C
Br
+ PhSH
NaH (1.3 equiv.)
solvent, rt.
Br
F2C
SPh
Br
PhS
FF
F3C
SPh
1
2a 3a 4a  
entry 
 
1 
(equiv.) 
solvent 
 
time   
(min)   
Yield
b
  
(%)   
2a/3a/4a
c 
 
1 3.0 THF 60   57   80/20/0 
2 3.0 1.4-dioxane 360   73   93/7/0 
3 1.0 1.4-dioxane 360   66   87/13/0 
4 5.0 1.4-dioxane 360   69   96/4/0 
5 3.0 DMF 10   trace
d
   - 
6 3.0 DMSO 10   trace
d
   - 
7 3.0 CH3CN 10   trace
d
   - 
8 3.0 Et2O 240   NR
e
   - 
9 3.0 toluene 240   NR
e
   - 
10
f
 1.2 EtOH 480   94   0/0/100 
a
 The reaction of 1 with PhSH (1.0 equiv) was carried out.  
b
 Isolated combined yield.   
c
 The ratio was determined by 
19
F NMR spectroscopy.  
d
 Major products were 4a.  
e
 No 
reaction.  
f 
KOH was used instead of NaH. See ref 5.                            .   
 
As the author determined the optimized reaction conditions, the substrate scope was 
next examined using 3.0 equivalents of 1 and various thiols in the presence of NaH (1.3 
equiv.) at room temperature.  Table 2 shows that the reaction smoothly proceeded with 
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a variety of substrates, affording the corresponding SN2’-type product 2b–2l in good to 
high yields with high to excellent selectivity.  The author addressed that the alkylthiols 
gave the corresponding SN2’-type products exclusively, in sharp contrast to arylthiols.  
From these findings, the author proposed that one factor for the occurrence of excessive 
SN2’-type reaction of 2 might be associated with the pKa value of thiols. 
 
Table 2. Substrate scope of SN2’-type reaction of 1
a
 
F3C
Br
+    RSH
F2C
Br
SR
Br
RS
FF
+
NaH (1.3 equiv.)
1,4-dioxane, rt.
1 2b-2l 3b-3l  
entry   
 
R 
 
time    
(h)    
2 
 
yield
b
  
 (%) 
2/3
c
 
   
 
1      2,4-MeC6H3 6       2b 84 94/6   
2    nC12H25 6     2c 82 >99/1   
3    tBu 3    2d 75 99/1   
4    Ph3C 3    2e 86 99/1   
5    PhCH2CH2 18    2f 82 99/1   
6    PhCH2 3    2g 88 99/1   
7    4-Me-C6H4CH2 7    2h 78 >99/1   
8    4-Cl-C6H4CH2 7    2i 73 99/1   
9    4-MeO-C6H4CH2 7    2j 75 >99/1   
10    2-Cl-C6H4CH2 4    2k 79 99/1   
11    2,4,6-Me-C6H2CH2 6    2l 77 >99/1   
a 
The reaction of 1 (3.0 equiv.) with RSH (1.0 equiv.) was carried out.  
b 
Isolated yield.  
c 
The ratio was determined by 
19
F NMR spectroscopy. 
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The author then examined synthetic applications of the obtained products 2.  
Although gem-difluoroallenes have greatly attracted attention due to their potential as 
difluorinated synthons, there is few the related study on the convenient synthesis of 
functionalized gem-difluoroallenes.
8
  Therefore, the author set out the examination of 
the synthesis of gem-difluoroallenyl sulfide from 2-bromo-3,3-difluoroallyl sulfide via a 
proper elimination reaction.  The author conducted the preliminary experiment with a 
slight excess amount of LDA (1.2 equiv.) in THF at –78 °C.  Unfortunately, the 
reaction resulted in the decomposition of 2a along with recovery of the unreacted 
starting material 2a.  There was no desired gem-difluoroallenyl sulfide 5a in the 
reaction mixture.  Then, the author employed 2d instead of 2a in the similar reaction 
conditions, which also led to a similar result.  Careful observation in these reactions 
made the author be aware of the incomplete consumption of 2a in spite of the excessive 
use of LDA.  This finding encouraged me to speculate that prior to full deprotonation 
of 2a by LDA, the produced product 5a might undergo next deprotonation process to 
generate the corresponding allenyl anion which may easily decompose.  To confirm 
this working hypothesis, the author performed the reaction of 2a with LDA (2.2 equiv.) 
in the presence of an excess amount of Me3SiCl (5.0 equiv.) in order to trap the 
generated allenyl anion.  The author found that the expecting reaction turned out to be 
complicated and the resulting mixture gave a lot of peaks by GC-MS analysis. The 
author observed that the reaction of 2d instead of 2a gave the gem-difluorosilylallenyl 
sulfide 6d in the reaction mixture by GC-MS.  The main GC-MS peak appeared at m/z 
= 179 (M
+–tBu) [MW = 236 (C10H18F2SSi)], which would probably correspond to the 
structure of 6d.  In order to get more information the author quenched the reaction and 
extracted the organic compounds.  The residual oil was purified by distillation to give 
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6d along with a small amount of inevitable contaminants.  The structure of 6d was 
supported by 
19
F and 
13
C NMR spectra.  Both typical terminal fluorine signals 
appeared at –103.5 ppm (s).  The central sp-carbon was appeared at 165.3 ppm (t, J = 
35.1 Hz) and two sp
2
-carbons at two ends of allenyl moiety appeared at 156.4 ppm (t, J 
= 259.3 Hz) and 134.4 ppm (t, J = 7.0 Hz) (Scheme 1).  Although the author purified 
the product using silica gel column chromatography, the process resulted in the 
decomposition of 6d as observed by multiple peaks in GC-MS analysis.  
 
SPh•
R2
F2C
5a, R2 = H
6a, R2 = SiMe3
F2C
Br
SR1
2d, R1 = tBu
StBu•
R2
F2C
5d, R2 = H
6d, R2 = SiMe3
LDA (2.2 equiv.)
Me3SiCl (5.0 equiv.)
-78℃, 10min
LDA (2.2 equiv.)
Me3SiCl (5.0 equiv.)
-78℃, 10min
2a, R1 = Ph 2
 
Scheme 1. Reaction of 2a and 2d with LDA in the presence of Me3SiCl 
 
Interestingly, when the author conducted the reaction of 2g with LDA (2.2 equiv.) in 
the presence of Et3SiCl (2.0 equiv.) in THF at –78 °C for 10 min, only one new peak in 
GC-MS analysis at m/z = 397 (M
+–Et) [MW = 426 (C22H36F2SSi2)] was observed.  
The later check of the reaction mixture would suggest the structure of 7g together with 
the unreacted 2g (ca. 40 %).  No complete consumption of the remaining 2g occurred 
while stirring at room temperature for prolonged reaction time.  In order to complete 
consumption of 2g the author performed a similar reaction with excess LDA (3.3 
equiv.) in the presence of excess Et3SiCl (3.0 equiv.).  The reaction smoothly 
proceeded to provide the unexpected gem-difluorohomoproparygyl thiol 8g in 82 % 
yield as a desilylated product of 7g after silica gel column purification (Scheme 2). 
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Br
F2C
S Ph
LDA (3.3 equiv.)
Et3SiCl (3.0 equiv.)
THF, -78℃, 10min
Et3Si
SSiEt3
Ph
F F
Et3Si
SH
Ph
F F
2g 7g 8g  
Scheme 2. Synthesis of gem-difluorohomopropargyl thiol 8g 
 
The structure of 8g was determined by 
1
H, 
13
C and 
19
F NMR spectra and FT-IR.  The 
methine proton signal of 8g was observed at 4.4 ppm (ddd, J = 12.3, 8.2, 6.4 Hz).  Two 
sp-carbon signals appeared at 94.4 ppm (t, J = 4.7 Hz) and 96.1 (t, J = 39.0 Hz).  Two 
signals of the geminal fluorines were observed at –85.0 ppm (dd, J = 267.0, 8.2 Hz) and 
–88.0 ppm (dd, J = 267.0, 12.2 Hz).  The characteristic peak at 2186 cm-1 in the FT-IR 
spectrum was assigned to CC triple bond stretching vibrations.  Unfortunately, the 
author noticed that this gem-difluorohomoproparygyl thiol 8g gradually turned yellow 
at room temperature after solvent removal, giving many peaks by GC-MS because of its 
unstable nature.  However, the author noticed that the promising transformation 
occurred from 8g to the novel fluorinated thiophene 10ga via the corresponding 
3,3-difluorodehydrothiophene 9g (Scheme 3).
9
  
 
S
F
PhEt3Si
Et3Si
F F
SH
Ph
S PhEt3Si
F
F
8g 9g 10ga  
Scheme 3. Synthesis of 2-phenyl-3-fluoro-5-triethylsilylthiophene 10ga 
 
On the basis of these findings, the author started to examine the overall transformation 
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reaction from 2g to 10ga.  Table 3 shows the selected reaction conditions of this 
one-pot synthesis of 3-fluorothiophene derivative 10g. 
 
Table 3. Screening of one-pot reaction conditions of 2g
a
 
Br
F2C
S Ph
LDA (3.3 equiv.)
R3SiCl (3.0 equiv.)
THF, -78℃, 10min
2g
work-up
silica gel column
S
F
PhR3Si
10g  
entry  R3SiCl work-up additive 10g Yield
b
 (%) 
1   Et3SiCl sat. NaHCO3 Et3N 10ga 82  
2   Et3SiCl sat. NaCl none 10ga 79  
3   Et3SiCl sat. NaCl Et3N 10ga 83  
4   Me3SiCl sat. NaCl Et3N 10gb 79  
5   PhMe2SiCl sat. NaCl Et3N 10gc 70
c 
 
6   Ph2MeSiCl sat. NaCl Et3N 10gd 45
d 
 
a 
2g (1.0 equiv.) and additive (1.0 equiv.) were used.  
b
 Isolated yield.  
c
 93 % Purity.   
d 
The corresponding desilylated 3-fluorothiphene derivatives 10ge was isolated in 29 %. 
 
After much screening of reaction parameters (including chlorosilane, work-up, and the 
additive), the author focused on the following three factors for generating 
2-phenyl-3-fluoro-5-triethylsilylthiophene 10ga in 83 % chemical yield (entry 3): (1) 
Chlorotriethylsilane (Et3SiCl) as an electrophile was the best. (2) It is necessary that the 
direct addition of aqueous sodium chloride solution to the reaction mixture at –78 °C 
was suitable for quenching the reaction. (3) The presence of triethylamine plays an 
important role for successive cyclization reaction.  It is beneficial that this one-pot 
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protocol requires only one time silica gel chromatographic purification. 
With the optimized reaction conditions in hand, the author examined the scope of this 
one-pot 3-fluorothiophene in order to synthesis of a series of 2-bromo-3,3-difluoroallyl 
sulfides 2f–2l. Regardless of the sulfides 2h–2k, the reaction similarly proceeded to 
give the corresponding 3-fluorothiophene derivative 10ha–10ka in high yields, 
respectively (Figure 1).  On the contrary, when the author conducted the reaction of 2f 
and 2l under the identical conditions no desired 3-fluorothiophene derivatives obtained 
but the corresponding gem-difluoroallene derivatives 5f and 5l did.  
 
SEt3Si
F
10ga (83%)
SMe3Si
F
SPhMe2Si
F
SPh2MeSi
F
SEt3Si
F
Me
SEt3Si
F
Cl
SEt3Si
F
OMe
SEt3Si
F
Cl
10gb (79%) 10gc (70%)
10gd (45%) 10ha (81%) 10ia (89%)
10ja (77%) 10ka (77%)  
Figure 1. 2-Aryl-3-fluoro-5-silylthiophenes 10 
 
On the basis of these experimental results, the author proposed the plausible reaction 
mechanism postulated in Scheme 4.  Initially, 2-bromo-3,3-difluoroallyl benzyl sulfide 
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2g undergoes deprotonation at the benzylic position instead of the allylic position, 
followed by [2,3]sigmatropic rearrangement to produce the corresponding 
gem-difluorohomopropargyl thiolate B.
10
  At this point, the silylated product C as 
possible intermediates have not been observed.  The bromoethylene moiety of the 
silylated product C was then transformed into the terminal acetylene by LDA followed 
by silylation at the terminal carbon to yield the product 7g.  Successive desilylation of 
7g under aqueous basic conditions proceeds to give the free 
gem-difluorohomopropargyl thiol 8g.  The resulting thiol 8g undergoes similar 
intramolecular cyclization in a 5-endodig fashion, as reported by Hammond.
11
  Finally, 
the resulting 4,4-difluoro-3,4-dihydrothiophene 9g easily undergoes aromatization on 
the silica gel column chromatography yielding the 3-fluorothiophene 10ga. 
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F2C
Br
S Ph
LDA F2C
Br
S Ph
[2,3]sigmatropic
rearrangement
PhS
Br
F
F
A B
Et3SiCl
PhEt3SiS
Br
F
F
C
PhEt3SiS
F
F
D
LDA
LDA
Et3SiCl
PhEt3SiS
F
F
SiEt3
Et3Si
Ph
Et3SiS
F
F
7g
=
desilylation Et3Si
Ph
HS
F
F
Et3Si
Ph
S
F
F
base
deprotonation
base・H
S PhEt3Si
F
F
5-end-dig aromatization
10ga
8g
E 9g
2g
 
Scheme 4. Plausible reaction mechanism for 3-fluorothiophene formation 
 
 
3.3. Conclusion 
 
In summary, the author has developed the first successful SN2’-type reaction of 
2-bromo-3,3,3-trifluoropropene 1 and a wide range of thiols.  The reaction opens the 
new route to provide the corresponding 2-bromo-3,3-difluoroallyl sulfides 2 in good to 
high yields with high to excellent selectivity.  In addition, the resulting 
2-bromo-3,3-difluoroallyl benzyl sulfides are efficiently transformed into the novel 
2-aryl-3-fluoro-5-triethylsilylthiophenes 10 in high yields.  
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3.4. Experimental 
 
3.4.1. General information 
1
H, 
13
C, and 
19
F NMR spectra were measured in CDCl3 solutions, unless otherwise 
stated.  Chemical shifts were given by δ relative to that of an internal Me4Si (TMS) for 
1
H NMR and 
13
C NMR spectra.  On the other hand, chemical shifts were given by δ 
relative to that of CFCl3 for 
19
F NMR spectra using an internal CF3C6H5 
(benzotrifluoride) or C6F6.  Infrared (IR) spectra are reported in cm
-1
.  Melting points 
are uncorrected.  
 
3.4.2. Preparation of 2g 
A 25 mL two-neck flask equipped with a magnetic stir bar, a stopcock and a three-way 
stopcock, was charged with 1 mL of hexane under argon.  To this solution was added 
NaH (63 % dispersion in mineral oil, 21.3 mg, 0.559 mmol, 1.3 equiv.).  After stirring 
for several minutes, the solvent was removed by syringe.  To this flask was added 1 
mL of 1,4-dioxane and benzylthiol (50.0 μL, 0.433 mmol, 1.0 equiv.).  After the 
mixture was stirred for 10 min at room temperature, the flask was immersed in an 
ultrasonic wave for 30 min and a cloudy white solution formed.  To this mixture was 
added 2-bromo-3,3,3-trifluoropropene (133 μL, 1.28 mmol, 3.0 equiv.) and stirred at 
room temperature until the complete consumption of benzylthiol (checked by GC-MS). 
To the mixture was added water (3 mL) and the resulting mixture was extracted with 
hexane (2 mL) three times.  The combined solution was dried over sodium sulphate, 
concentrated in vacuo then the residual oil was purified by chromatography on silica gel 
column (hexane as an eluent) to give 2g (105.6 mg, 88 %) as colorless oil. 
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3.4.3. Preparation of 10ga 
A solution of N,N-diisopropylamine (357 μL, 2.55 mmol, 3.3 equiv.) in THF (3 mL) 
was cooled to 0 °C and treated with nBuLi (1.57 mL of 1.62 M solution in hexane, 2.55 
mmol, 3.3 equiv.).  The resulting solution was cooled to –78 °C and to this solution 
was added Et3SiCl (389 μL, 2.32 mmol, 3.0 equiv.).  After 10 min, the solution was 
treated drop-wise with 2g (215.7 mg, 0.773 mmol, 1.0 equiv.) in THF solution.  The 
reaction mixture was stirred for 10 min, and then quenched with saturated aqueous 
solution of NaCl (3 mL) at –78 °C.  To the resulting solution was added triethylamine 
(108 μL, 0.773 mmol, 1.0 equiv.) at this temperature and the mixture was gradually 
warmed to room temperature.  After stirring for 1 day, the mixture was extracted with 
hexane/ether = 3/1 (2 mL) three times.  The combined solution was dried over sodium 
sulphate, concentrated in vacuo then the residual oil was purified by chromatography on 
silica gel column (hexane as an eluent) to give 10ga (187.8 mg, 83 %) as colorless oil.  
 
3.4.4. Data of products (2a–2l, 10ga-10ge, 10ha-10ka) 
(2-bromo-3,3-difluoroallyl)(phenyl)sulfane (2a) 
Colorless oil; yield 73 %; IR (NaCl) 3060, 1734, 1480, 1439, 1281, 1195, 1139, 979, 
744, 691 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.50–7.44 (m, 2H), 7.34–7.29 (m, 3H), 
3.77–3.74 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ154.1 (dd, J = 291.1, 287.2 Hz), 
136.6, 132.7, 129.0, 128.0, 78.3 (dd, J = 36.6, 21.8 Hz), 37.2; 
19
F NMR (CDCl3, 376 
MHz) δ–83.0 (d, J = 34.5 Hz, 1F) –88.7 (d, J = 34.5 Hz, 1F); GC-MS (EI, m/z, 70 eV) 
266 (32, M
+
[
81
Br]), 264 (31, M
+
[
79
Br]), 185 (93), 165 (100), 157 (72), 155 (73), 131 
(15), 129 (15), 109 (95), 65 (33). 
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(2-bromo-3,3-difluoroallyl)(2,4-dimethylphenyl)sulfane (2b) 
Colorless oil; yield 84 %; IR (NaCl) 2923, 1734, 1603, 1479, 1280, 1195, 1139, 979, 
813 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.33 (d, J = 7.8 Hz, 1H), 7.05 (d, J = 0.6 Hz, 
1H), 6.98–6.94 (m, 1H), 3.67–3.65 (m, 2H), 2.45 (s, 3H), 2.30 (s, 3H); 13C NMR 
(CDCl3, 101 MHz) δ 154.0 (dd, J = 291.1, 287.2 Hz), 140.8, 138.4, 134.1, 131.2, 128.6, 
127.2, 78.2 (dd, J = 36.6, 21.8 Hz), 36.7, 21.0, 20.6; 
19
F NMR (CDCl3, 376 MHz) δ 
–83.2 (d, J = 34.1 Hz), –89.1 (d, J = 34.1 Hz); GC-MS (EI, m/z, 70 eV) 294 (45, 
M
+
[
81
Br]), 292 (44, M
+
[
79
Br]), 213 (49), 193 (51), 157 (11), 155 (13), 137 (100), 93 
(17), 91 (34), 77 (20). 
  
(2-bromo-3,3-difluoroallyl)(dodecyl)sulfane (2c) 
Colorless oil; yield 82 %; IR (NaCl) 2976, 2854, 1733, 1466, 1277, 1135, 977 cm
-1
; 
1
H 
NMR (CDCl3, 300 MHz) δ 3.46 (dd, J = 2.8, 2.0 Hz, 2H), 2.50 (t, J = 7.3 Hz, 2H), 
1.64–1.55 (m, 2H), 1.56–1.19 (m, 18H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 75 
MHz) δ 153.8 (dd, J = 290.3, 287.2 Hz), 79.1 (dd, J = 37.3, 21.1 Hz), 33.0, 31.9, 31.4, 
29.61, 29.60, 29.50, 29.3, 29.15, 29.12, 28.8, 22.7, 14.1; 
19
F NMR (CDCl3, 283 MHz) δ 
–83.4 (dt, J = 38.3, 2.0 Hz, 1F), –89.3 (dt, J = 38.3, 2.8 Hz, 1F); GC-MS (EI, m/z, 70 
eV) 358 (1, M
+
[
81
Br]), 356 (1, M
+
[
79
Br]), 201 (100), 157 (15), 155 (15), 111 (4), 97 (9), 
83 (11), 69 (16), 55 (15); Anal. Calcd. for C15H27BrF2S: C, 50.42; H, 7.62. Found: C, 
50.68; H, 7.64. 
 
tert-butyl(2-bromo-3,3-difluoroallyl)sulfane (2d) 
Colorless oil; yield 75 %; IR (NaCl) 2964, 1737, 1459, 1365, 1277, 1184, 1137, 
975cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 3.53–3.49 (m, 2H), 1.36 (s, 9H); 
13
C NMR 
 51 
(CDCl3, 101 MHz) δ 153.0 (dd, J = 290.3, 286.5 Hz), 79.6 (dd, J = 37.4, 21.8 Hz), 43.0, 
30.8, 30.1; 
19
F NMR (CDCl3, 376 MHz) δ –83.5 (d, J = 38.1 Hz, 1F), –88.3–(–88.5) (m, 
1F); GC-MS (EI, m/z, 70 eV) 246 (29, M
+
[
81
Br]), 244 (29, M
+
[
79
Br]), 157 (21), 155 (22), 
139 (3), 137 (3), 131 (7), 129 (7), 75 (8), 57 (100); Anal. Calcd. for C7H11BrF2S: C, 
34.30; H, 4.52. Found: C, 34.49; H, 4.60. 
 
(2-bromo-3,3-difluoroallyl)(trityl)sulfane (2e) 
White solid; yield 86 %; mp: 92.0–93.3 ℃; IR (KBr) 3028, 1745, 1593, 1487, 1444, 
1278, 1185, 1139, 980, 744, 700 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.44–7.40 (m, 6H), 
7.33–7.20 (m, 9H), 3.11–3.08 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ 153.3 (dd, J = 
291.9, 286.5 Hz), 144.1, 129.5, 128.0, 76.8 (dd, J = 38.1, 23.1 Hz), 67.2, 33.3, 128; 
19
F 
NMR (CDCl3, 376 MHz) δ –82.6 (d, J = 34.1 Hz, 1F), –86.9–(–87.2) (m, 1F); Anal. 
Calcd. for C22H17BrF2S: C, 61.26; H, 3.97. Found: C, 61.27; H, 3.97. 
 
(2-bromo-3,3-difluoroallyl)(phenethyl)sulfane (2f) 
Colorless oil; yield 82 %; IR (NaCl) 3004, 2921, 1733, 1497, 1454, 1278, 1134, 979, 
736, 698 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.34–7.28 (m, 2H), 7.26–7.18 (m, 3H), 
3.48–3.45 (m, 2H), 2.92–2.86 (m, 2H), 2.79–2.73 (m, 2H); 13C NMR (CDCl3, 101 
MHz) δ 153.9 (dd, J = 290.4, 288.1 Hz), 140.0, 128.5, 128.4, 126.5, 78.9 (dd, J = 36.6, 
21.0 Hz), 35.9, 33.1, 32.8; 
19
F NMR (CDCl3, 376 MHz) δ –83.0 (d, J = 35.4 Hz, 1F), 
–88.8 (d, J = 35.4 Hz, 1F); GC-MS (EI, m/z, 70 eV) 294 (25, M+[81Br]), 292 (25, 
M
+
[
79
Br]), 203 (25), 201 (15), 157 (34), 155 (35), 137 (33), 104 (41), 91 (100), 77 (16);  
Anal. Calcd. for C11H11BrF2S: C, 45.07; H, 3.78. Found: C, 45.19; H, 3.72. 
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benzyl(2-bromo-3,3-difluoroallyl)sulfane (2g) 
Colorless oil; yield 88 %; IR (NaCl) 2922, 1733, 1494, 1453, 1408, 1278, 1196, 1134, 
980, 700 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.35–7.25 (m, 5H), 3.73 (s, 2H), 
3.39–3.35 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 153.6 (dd, J = 290.9, 287.8 Hz), 
137.3, 128.8, 128.5, 127.2, 79.0 (dd, J = 36.7, 21.2 Hz), 35.9, 32.4; 
19
F NMR (CDCl3, 
376 MHz) δ –82.8 (d, J = 36.7 Hz, 1F), –88.1 (d, J = 36.7 Hz, 1F); GC-MS (EI, m/z, 70 
eV) 280 (8, M
+
[
81
Br]), 278 (8, M
+
[
79
Br]), 179 (2), 157 (2), 155 (2), 131 (2), 129 (2), 122 
(5), 91 (100), 77(5); HRMS (FAB, m/z) Calcd. for C10H9BrF2S: 277.9576; Found: 
277.9565. 
 
(4-methylbenzyl)(2-bromo-3,3-difluoroallyl)sulfane (2h) 
Colorless oil; yield 78 %; IR (NaCl) 2921, 1733, 1514, 1277, 1196, 1134, 980, 819 
cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.21 (d, J = 7.8 Hz, 2H), 7.12 (d, J = 7.8 Hz, 2H), 
3.69 (s, 2H), 3.37–3.34 (m, 2H), 2.33 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 153.6 (dd, 
J = 290.4, 287.2 Hz), 136.9, 134.1, 129.2, 128.8, 79.1 (dd, J = 37.4, 21.8 Hz), 35.5, 32.3, 
21.1; 
19
F NMR (CDCl3, 376 MHz) δ –82.9 (d, J = 35.7 Hz, 1F), –88.1 (d, J = 35.7 Hz, 
1F); GC-MS (EI, m/z, 70 eV) 294 (14, M
+
[
81
Br]), 292 (13, M
+
[
79
Br]), 157 (2), 155 (2), 
137 (3), 135 (3), 105 (100), 103 (7), 91 (6), 77 (9); Anal. Calcd. for C11H11BrF2S: C, 
45.07; H, 3.78. Found: C, 45.02; H, 3.76. 
 
(4-chlorobenzyl)(2-bromo-3,3-difluoroallyl)sulfane (2i) 
Colorless oil; yield 73 %; IR (NaCl) 2836, 1733, 1611, 1512, 1277, 1249, 1176, 1035, 
980, 830 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.32–7.25 (m, 4H), 3.69 (s, 2H), 
3.37–3.34 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ153.6 (dd, J = 291.2, 288.0 Hz), 
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135.8, 133.0, 130.2, 128.7, 78.8 (dd, J = 36.6, 21.0 Hz), 35.0, 32.4; 
19
F NMR (CDCl3, 
376 MHz) δ–82.6 (d, J = 35.4 Hz, 1F), –88.0 (d, J = 35.4 Hz, 1F); GC-MS (EI, m/z, 70 
eV) 316 (5, M
+
[
81
Br]), 314 (17, M
+
[
79
Br]), 312 (13), 157 (6), 155 (6), 127 (34), 125 
(100), 99 (4), 89 (12), 75 (5); Anal. Calcd. for C10H8BrClF2S: C, 38.30; H, 2.57. Found: 
C, 38.46; H, 2.47. 
 
(4-methoxybenzyl)(2-bromo-3,3-difluoroallyl)sulfane (2j) 
Colorless oil; yield 75 %; IR (NaCl) 2920, 1732, 1592, 1490, 1442, 1407, 1278, 1197, 
1135, 1093, 1015, 981, 828 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.25 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H), 3.68 (s, 2H), 3.37–3.34 (m, 2H); 13C NMR 
(CDCl3, 101 MHz) δ158.7, 153.6 (dd, J = 290.4, 287.2 Hz), 129.9, 129.1, 113.9, 79.1 
(dd, J = 36.6, 21.0 Hz), 55.2, 35.1, 32.2; 
19
F NMR (CDCl3, 376 MHz) δ–82.9 (d, J = 
35.4 Hz, 1F), –88.2 (d, J = 35.4 Hz, 1F); GC-MS (EI, m/z, 70 eV) 310 (8, M+[81Br]), 
308 (8, M
+
[
79
Br]), 155 (2), 153 (2), 138 (2), 121 (100), 109 (4), 107 (2), 91 (4), 77 (7); 
Anal. Calcd. for C11H11BrF2OS: C, 42.73; H, 3.59. Found: C, 42.84; H, 3.52. 
 
(2-chlorobenzyl)(2-bromo-3,3-difluoroallyl)sulfane (2k) 
Colorless oil; yield 79 %; IR (NaCl) 3020, 2926, 1733, 1472, 1444, 1279, 1196, 1135, 
981, 743 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.40–7.30 (m, 2H), 7.28–7.19 (m, 2H), 
3.85 (s, 2H), 3.46–3.43 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ153.7 (dd, J = 290.4, 
287.2 Hz), 135.0, 134.2, 130.5, 129.9, 128.7, 126.8, 78.9 (dd, J = 36.6, 21.0 Hz), 33.4, 
32.9; 
19
F NMR (CDCl3, 376 MHz) δ–82.5 (d, J = 36.8 Hz, 1F), –88.1 (d, J = 36.8 Hz, 
1F); GC-MS (EI, m/z, 70 eV) 316 (5, M
+
[
81
Br]), 314 (19, M
+
[
79
Br]), 312 (14), 157 (7), 
156 (6), 155 (6), 127 (34), 125 (100), 89 (12), 75 (6); Anal. Calcd. for C10H8BrClF2S: C, 
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38.30; H, 2.57. Found: C, 38.43; H, 2.58. 
 
(2,4,6-trimethylbenzyl)(2-bromo-3,3-difluoroallyl)sulfane (2l) 
White solid; yield 77 %; mp: 38.1–38.8 ℃; IR (KBr) 2920, 1733, 1613, 1278, 1193, 
1134, 978, 850 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ6.84 (s, 2H), 3.75 (s, 2H), 
3.55–3.52 (m, 2H), 2.39 (s, 6H), 2.25 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ153.8 (dd, 
J = 290.3, 287.2 Hz), 137.1, 136.9, 129.6, 129.0, 79.0 (dd, J = 37.4, 21.0 Hz), 34.2, 30.8, 
20.9, 19.4; 
19
F NMR (CDCl3, 376 MHz) δ–83.3 (d, J = 36.7 Hz, 1F), –88.7 (d, J = 36.7 
Hz, 1F); GC-MS (EI, m/z, 70 eV) 266 (32, M
+
[
81
Br]), 264 (31, M
+
[
79
Br]), 185 (93), 165 
(100), 157 (72), 155 (73), 131 (15), 129 (15), 109 (95), 65 (33); Anal. Calcd. for 
C13H15BrF2S: C, 48.61; H, 4.71. Found: C, 48.83; H, 4.65. 
 
triethyl(4-fluoro-5-phenylthiophen-2-yl)silane (10ga) 
Colorless oil; yield 82 %; IR (NaCl) 2956, 2876, 1602, 1555, 1495, 1360, 1237, 1016, 
963, 828 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.66–7.60 (m, 2H), 7.41–7.30 (m, 2H), 
7.23–7.20 (m, 1H), 6.97 (s, 1H), 1.02 (t, J = 7.8 Hz, 9H), 0.82 (q, J = 7.8 Hz, 6H); 13C 
NMR (CDCl3, 101 MHz) δ155.1 (d, J = 263.9 Hz), 133.7 (d, J = 4.7 Hz), 131.5 (d, J = 
3.9 Hz), 128.7, 127.3, 126.6 (d, J = 5.4 Hz), 126.3 (d, J = 13.2 Hz), 125.4 (d, J = 24.9 
Hz), 7.2, 4.0; 
19
F NMR (CDCl3, 376 MHz) δ–131.9 (s); GC-MS (EI, m/z, 70 eV) 292 
(64, M
+
), 263 (79), 235 (66), 207 (100), 191 (3), 173 (3), 158 (4), 127 (6), 118 (6), 104 
(11); Anal. Calcd. for C16H21FSSi: C, 65.70; H, 7.24;. Found: C, 65.78; H, 7.20. 
 
(4-fluoro-5-phenylthiophen-2-yl)trimethylsilane (10gb) 
Colorless oil; yield 79 %; IR (NaCl) 2957, 2896, 1602, 1573, 1557, 1494, 1362, 1251, 
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1035, 963, 842, 758, 690 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.63 (d, J = 7.6 Hz, 2H), 
7.41–7.35 (m, 2H), 7.29–7.22 (m, 1H), 6.98 (s, 1H), 0.33 (s, 9H); 13C NMR (CDCl3, 
101 MHz) δ155.1 (d, J = 264.7 Hz), 136.9 (d, J = 4.7 Hz), 131.5 (d, J = 3.8 Hz), 128.8, 
127.3, 126.6 (d, J = 4.7 Hz), 126.2 (d, J = 14.0 Hz), 124.7 (d, J = 24.9 Hz), –0.57; 19F 
NMR (CDCl3, 376 MHz) δ–131.7 (s); GC-MS (EI, m/z, 70 eV) 250 (43, M
+
), 235 (100), 
205 (1), 191 (1), 171 (2), 158 (2), 133 (3), 118 (6), 95 (1), 77 (15); Anal. Calcd. for 
C13H15FSSi: C, 62.35; H, 6.04. Found: C, 62.38; H, 6.04. 
 
(4-fluoro-5-phenylthiophen-2-yl)dimethyl(phenyl)silane (10gc) 
Colorless oil; yield 70 % (93 % purity); IR (NaCl) 2958, 1665, 1601, 1574, 1555, 1494, 
1428, 1362, 1252, 1111, 1035, 963, 810 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.64–7.56 
(m, 4H), 7.42–7.34 (m, 5H), 7.26 (d, J = 6.9 Hz, 1H), 6.99 (s, 1H), 0.6 (s, 6H); 13C 
NMR (CDCl3, 101 MHz) δ155.1 (d, J = 264.7 Hz), 136.6, 134.8 (d, J = 4.7 Hz), 133.9, 
131.4 (d, J = 3.9 Hz), 129.7, 128.8, 128.0, 127.5, 127.0 (d, J = 13.2 Hz), 126.7 (d, J = 
4.6 Hz), 126.0 (d, J = 24.9 Hz), 0.84; 
19
F NMR (CDCl3, 376 MHz) δ–131.5 (s); 
GC-MS (EI, m/z, 70 eV) 312 (51), 297 (100), 254 (2), 235 (3), 202 (5), 139 (10), 105 
(3), 91 (4), 77 (4), 53 (1); HRMS (FAB, m/z) Calcd. for C18H17FSSi: 312.0804; Found: 
312.0802. 
 
(4-fluoro-5-phenylthiophen-2-yl)(methyl)diphenylsilane (10gd) 
Colorless oil; yield 45 %; IR (NaCl) 3087, 1589, 1446, 1362, 1255, 1111, 1035, 963, 
791, 728, 698 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.64–7.56 (m, 6H), 7.47–7.33 (m, 
8H), 7.29–7.25 (m, 1H), 7.01 (s, 1H), 0.87 (s, 3H); 13C NMR (CDCl3, 101 MHz) 
δ155.1 (d, J = 264.7 Hz), 135.0, 134.7, 132.7 (d, J = 4.7 Hz), 131.3 (d, J = 3.9 Hz), 
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129.4 (d, J = 18.3 Hz), 128.3, 128.0, 127.9, 127.6 (d, J = 2.3 Hz), 127.3, 126.7 (d, J = 
4.7 Hz), –2.8; 19F NMR (CDCl3, 376 MHz) δ–131.3 (s); GC-MS (EI, m/z, 70 eV) 374 
(64, M
+
), 359 (100), 297 (10), 281 (5), 202 (8), 180 (6), 155 (3), 139 (7), 105 (5), 91 
(2); Anal. Calcd. for C23H19FSSi: C, 73.75; H, 5.11. Found: C, 73.91; H, 4.97. 
 
triethyl(4-fluoro-5-p-tolylthiophen-2-yl)silane (10ha) 
Colorless oil; yield 81 %; IR (NaCl) 2956, 2911, 2876, 1571, 1556, 1509, 1455, 1358, 
1189, 1018, 963, 828, 738 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.53 (d, J = 7.8 Hz, 2H), 
7.19 (d, J = 7.8 Hz, 2H), 6.96 (s, 1H), 2.36 (s, 3H), 1.01 (t, J = 8.0 Hz, 9H), 0.798 (q, J 
= 8.0 Hz, 6H); 
13
C NMR (CDCl3, 101 MHz) δ154.9 (d, J = 263.1 Hz), 137.2, 133.0 (d, 
J = 4.7 Hz), 154.9 (d, J = 263.1 Hz), 129.4, 128.7 (d, J = 3.9 Hz), 126.4 (d, J = 12.9 Hz), 
125.4 (d, J = 24.9 Hz), 21.2, 7.3, 4.1; 
19
F NMR (CDCl3, 376 MHz) δ–132.6 (s); 
GC-MS (EI, m/z, 70 eV) 306 (78, M
+
), 277 (81), 249 (69), 221 (100), 205 (6), 171 (7), 
139 (8), 125 (7), 111 (15); Anal. Calcd. for C17H23FSSi: C, 66.61; H, 7.56. Found: C, 
66.82; H, 7.60. 
 
[5-(4-chlorophenyl)-4-fluorothiophen-2-yl]triethylsilane (10ia) 
Colorless oil; yield 89 %; IR (NaCl) 2956, 2876, 1568, 1553, 1492, 1358, 1238, 1095, 
1018, 828 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.57 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.4 
Hz, 2H), 6.97 (s, 1H), 1.02 (t, J = 7.8 Hz, 9H), 0.803 (q, J = 7.8 Hz, 6H); 
13
C NMR 
(CDCl3, 101 MHz) δ155.3 (d, J = 264.7 Hz), 134.3 (d, J = 4.7 Hz), 133.1 (d, J = 1.6 
Hz), 130.0 (d, J = 3.9 Hz), 128.9, 127.7 (d, J = 5.4 Hz), 125.5 (d, J = 24.9 Hz), 125.0 (d, 
J = 13.2 Hz), 7.2, 4.0; 
19
F NMR (CDCl3, 376 MHz) δ–131.1 (s); GC-MS (EI, m/z, 70 
eV) 328 (28, M
+
[
37
Cl]), 326 (66, M
+
[
35
Cl]), 299 (33), 297 (79), 271 (28), 269 (67), 243 
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(41), 241 (100), 205 (7), 121 (14); Anal. Calcd. for C16H20ClFSSi: C, 58.78; H, 6.17. 
Found: C, 58.91; H, 6.17. 
 
Triethyl[4-fluoro-5-(4-methoxyphenyl)thiophen-2-yl]silane (10ja) 
Colorless oil; yield 77 %; IR (NaCl) 2955, 2910, 2876, 1610, 1558, 1509, 1440, 1358, 
1293, 1249, 1181, 1039, 1018, 830 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.56 (d, J = 8.6 
Hz, 2H), 6.95 (s, 1H), 6.92 (d, J = 8.6 Hz, 2H), 3.83 (s, 3H), 1.02 (t, J = 8.0 Hz, 9H), 
0.797 (q, J = 8.0 Hz, 6H); 
13
C NMR (CDCl3, 101 MHz) δ158.9, 154.4 (d, J = 262.4 Hz), 
132.3 (d, J = 4.7 Hz), 127.9 (d, J = 4.6 Hz), 126.2 (d, J = 25.0 Hz), 125.4 (d, J = 2.5 Hz), 
124.2 (d, J = 4.8 Hz), 114.2, 55.3, 7.2, 4.0; 
19
F NMR (CDCl3, 376 MHz) δ–133.7 (s); 
GC-MS (EI, m/z, 70 eV) 322 (97, M
+
), 293 (76), 265 (69), 237 (100), 222 (6), 173 (4), 
145 (5), 133 (10), 119 (25), 77 (4); Anal. Calcd. for C17H23FOSSi: C, 63.31; H, 7.19. 
Found: C, 63.48; H, 7.13. 
 
[5-(2-chlorophenyl)-4-fluorothiophen-2-yl]triethylsilane (10ka) 
Colorless oil; yield 77 %; IR (NaCl) 2956, 2876, 1567, 1444, 1360, 1238, 1069, 1017, 
964, 827 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ7.49–7.40 (m, 2H), 7.30–7.25 (m, 2H),  
6.98 (s, 1H), 1.03 (t, J = 8.0 Hz, 9H), 0.817 (q, J = 8.0 Hz, 6H); 
13
C NMR (CDCl3, 101 
MHz) δ155.6 (d, J = 264.7 Hz), 136.1 (d, J = 4.6 Hz), 133.6, 132.2 (d, J = 3.1 Hz), 
130.1, 129.9 (d, J = 3.1 Hz), 129.3, 126.6, 123.9 (d, J = 24.1 Hz), 122.9 (d, J = 16.3 Hz), 
7.3, 4.1; 
19
F NMR (CDCl3, 376 MHz) δ–129.3 (s); GC-MS (EI, m/z, 70 eV) 328 (22, 
M
+
[
37
Cl]), 326 (51, M
+
[
35
Cl]), 299 (32), 297 (79), 271 (26), 269 (62), 243 (41), 241 
(100), 158 (10), 121 (22); Anal. Calcd. for C16H20ClFSSi: C, 58.78; H, 6.17. Found: C, 
58.87; H, 6.03. 
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3-Fluoro-2-phenylthiophene (10ge) 
Colorless oil; yield 29 %; 
1
H NMR (CDCl3, 400 MHz) δ7.64–7.59 (m, 1H), 7.41–7.37 
(m, 1H), 7.35–7.30 (m, 1H), 7.12 (dd, J = 5.5, 3.9 Hz, 1H), 6.87 (d, J = 5.5 Hz, 1H); 13C 
NMR (CDCl3, 101 MHz) δ153.9 (d, J = 260.8 Hz), 134.4, 131.2 (d, J = 3.9 Hz), 128.8, 
127.4, 126.7 (d, J = 4.7 Hz), 122.0 (d, J = 10.1 Hz), 118.7 (d, J = 27.2 Hz); 
19
F NMR 
(CDCl3, 376 MHz) δ131.6 (d, J = 2.8 Hz) (s); GC-MS (EI, m/z, 70 eV) 178 (100, M
+
), 
158 (4), 146 (10), 133 (22), 126 (2), 107 (4), 89 (5), 77 (2), 69 (2), 51 (1). 
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Chapter four 
Synthesis of mono-Fluorinated  
Functionalized Cyclopropanes and Aziridines  
using the (-Fluorovinyl)diphenylsulfonium Salt 
 
 
4.1. Introduction 
 
-(Trifluoromethyl)vinyl sulfonium salt is a powerful building block for the synthesis 
of trifluoromethylated compounds such as cyclopropanes, aziridines, and 
-(trifluoromethyl)vinyl molecules.1  Among them, trifluoromethylated cyclopropanes 
are attractive products due to their high reactivity.  In a similar sense, 
mono-fluorinated cyclopropanes have drawn much attention due to their wide utility as 
precursors of medicinal materials.
2
  There are a large number of examples using 
addition reactions of fluorocarbenes to olefins or carbenes to fluoroolefins in the 
literature.
3
  On the other hand, the synthesis of such molecules using annulation 
reactions is scarce.
2a,4
  The author considered that these molecules may be accessible 
from appropriate active methylene compounds and the monofluorinated vinyl sulfonium 
salt under mild conditions.  To the best of my knowledge, there is no report so far 
concerning the mono-fluorinated vinyl sulfonium salt.  The author discloses the first 
preparation of -fluorovinyl sulfonium salt and its synthetic applications. 
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4.2. Results and discussion 
 
The author planned the synthetic route of 1 is shown in Scheme 1.  Because our 
group has already reported the facile preparation of the requisite α-fluorovinyl phenyl 
sulfide 2 from (1-fluorovinyl)methyldiphenylsilane 3.
5,6
  According to the reported 
procedure, the author next examined the quarternization of 2 with diphenyliodonium 
triflate in the presence of a catalytic amount of CuCl(I).
1
  As the author expected, the 
reaction proceeded giving the desired salt 1.  To my disappointment, the reaction 
mixture generally turned black during the progress of quarternization.  To make 
matters worse, the resulting contaminated reaction mixtures required tedious 
purification steps.  The extra process caused decrease of the yield.  In order to avoid 
this unfavorable color-change, the author investigated more preferable reaction 
conditions.  After many unsuccessful attempts, the author reached the acceptable 
reaction conditions.  Thus, when the reaction was carried out using 2 (0.95 equiv.) and 
diphenyliodonium triflate (1.0 equiv.) in the presence of Cu powder (5.0 equiv.) instead 
of CuCl(I) in dichloroethane (DCE) under reflux conditions for 30 min, the author 
obtained 1 as a white solid in 67 % yield after purification by silica gel column 
chromatography.  The salt 1 is also free-flowing, shelf-stable, and easy to handle, as is 
often the case with vinyl sulfonium triflates.  
 
3 2 (93%) 1 (67%)
SiPh2Me
F
SPh
F
[Ph2I]TfO
Cu powder
DCE, reflux, 30min
PhSSO2Ph
CsF
DMF, 80℃
ref 5
S+Ph2・TfO
-
F
 
Scheme 1. Synthesis of (-fluorovinyl)sulfonium salt 1 
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With the practical procedure of 1 in hand, the author examined the reactivity of 1.  
The model reaction was tested using 1 (1.2 equiv.) and 2-(phenylsulfonyl)acetonitrile 4 
(1.0 equiv.) at room temperature in the presence of DBU (1.2 equiv.) as a base in 
DMSO.
7
  The expected cyclization reaction proceeded with ease to give the desired 
mono-fluorinated cyclopropane derivative 5a as a mixture of diastereomers (92/8) in 
89 % combined yield.  Unfortunately, this diasteromeric mixture could not be easily 
separated into its components.  To improve both chemical yield and 
diastereoselectivity, the author optimized the reaction conditions relative to the 
parameters such as solvent and base.  The results are shown in Table 1.  Most 
reaction conditions tested still keep the yield within an acceptable range with high 
diastereoselectivity.  Taking both yield and diastereoselectivity into consideration in 
Table 1, the author determined that the reaction conditions of entry 2 were best. 
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Table 1. Optimization of reaction conditions
a
 
S+Ph2・TfO
-
F
+
CN
SO2Ph
base (1.2 equiv.)
solvent, r.t., 30min
F
SO2Ph
CN
1 4 5a  
entry  solvent base yield
b
 (%) dr
c
 
1   DMSO DBU 89 92/8 
2 CH3CN DBU 93 95/5 
3 DCM DBU 76 96/4 
4 DMSO/THF (1/1) DBU 89 93/7 
5 THF DBU 91 95/5 
6 DMSO NaH 87 92/8 
7 DMSO tBuOK 39 92/8 
8 DMSO K2CO3
d
 69 93/7 
9 AcOEt K2CO3
d
 89 96/4 
a
 The reaction of 1 (1.2 equiv.) with 4 (1.0 equiv.) was carried out.  
b
 Isolated yield.   
c
 Determined by 
1
H or 
19
F NMR.  
d
 K2CO3 (3.0 equiv.) was used. 
 
As far as the stereochemistry of 5a is concerned, the author performed the X-ray 
analysis of 5a.  Actually, the major isomer 5a was confirmed by X-ray analysis 
(Figure 1).
8
  The ORTEP drawing of 5a revealed that there was a cis-relationship 
between the vicinal fluoro and cyano groups. 
 
  
 
 
 65 
                                                            
 
 
 
F
SO2Ph
CN
5a  
 
 
Figure 1. Xray structure of 5a 
 
Having found the optimal conditions, the author explored the substrate scope of this 
cyclization protocol (Table 2).  A variety of active methylene compounds bearing a 
wide range of electron-withdrawing groups took part in this reaction, affording the 
corresponding mono-fluorinated cyclopropane derivatives 5 in good to excellent yields.  
Reaction substrates having highly polar amide or imido groups underwent smooth 
cyclization (entries 3, 8).  Among the products, the product 5d (entry 4) was more 
volatile than other products.  That is the reason why the product 5d was obtained in 
slightly low yield.  Although the author made considerable effort (prolonged reaction 
time, elevated temperature, and increased amount of the base) for the reaction of entries 
5–7, complete reactions were not achieved.  These observations also supported slightly 
decreased yields.  It is noteworthy that all active methylene compounds containing a 
cyano group gave high diastereoselectivity of the product (entries 1–4).  The 
stereochemistry of all these major products except for 5a was tentatively assigned by 
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analogy as shown in Table 2 on the basis of 
1
H and 
19
F NMR data in comparison with 
that of 5a.  When the author conducted the reaction of tert-butyl acetoacetate (entry 5) 
containing a ketone functionality in the cyclization reaction, obtained was a small 
amount of an inseparable unidentified by-product in addition to two diastereomers of 
the corresponding monofluorinated cyclopropanes 5e. 
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+
EWG1
EWG2
DBU (1.2 equiv.)
CH3CN, rt., 30min
F
EWG2
EWG1
4 5
S+Ph2・TfO
-
F
1  
entry substrate product
b
 5 yield (%)
c
 dr
d
 
1   
CN
CO2EE  
F
CO2EE
CN
 
5b 98 91/9 
2
e
  
CN
CONH2  
F
CONH2
CN
 
5c 79 98/2 
   3  
CN
P(O)(OEt)2  
F
P(O)(OEt)2
CN
 
5d 70 91/9 
4  
COMe
CO2tBu  
F
CO2tBu
COMe
 
5e 79 (86)
 f
 72/28 
5  
SO2Ph
CO2Me  
F
CO2Me
SO2Ph
 
5f 83 (94) 50/50 
6  
CO2Bn
CO2Bn  
F
CO2Bn
CO2Bn
 
5g 77 (91) - 
7  
SO2Ph
SO2Ph  
F
SO2Ph
SO2Ph
 
5h 93 - 
8  
N
N
O
O
O
 
N
N
O
O
O
F
 
5i 96 - 
a
 The reaction of 1 (1.2 equiv.) with 4 (1.0 equiv.) was carried out.  
b
 Major stereoisomer is 
shown.  
c
 Isolated yield and The yield based on the consumed starting material in 
parentheses.  
d
 Determined by 
1
H or 
19
F NMR.  
e
 EE = ethoxyethyl.  
f
 Percent yield is 
including a small amount of an unidentified product.                         .  
 
Table 2. Substrate scope
a
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The author tried to appeal the utility of the salt 1.  The next target molecule was 
selected to the corresponding aziridine.  The cyclization reaction of 1 with a primary 
amine was expected to produce mono-fluorinated aziridine (Scheme 2).
9
  Referring to 
our previous procedure for the synthesis 2-trifluoromethyl-N-Ts-aziridine,
10
 the reaction 
of 1 and p-toluenesulfonamide (TsNH2) was conducted in the presence of NaH in THF.  
As the result, the reaction proceeded affording the corresponding 
2-fluoro-N-Ts-aziridine 6a in 72 % yield as a white solid.  This is the first example of 
the preparation of 6a.  The author believes that this free-flowing and easy-handling 
aziridine 6a should come to be a versatile mono-fluorinated building block of 
nitrogen-containing biologically active molecules.  In addition to TsNH2, 
β-phenethylamine as a primary alkyl amine participated in this aziridination reaction.  
Thus, the reaction of 1 and β-phenethylamine was carried out in the presence of tBuNH2 
in DMSO at room temperature, giving the corresponding 2-trifluoromethyl- 
N-β-phenethyl-aziridine 6b in 48 % yield.9a 
 
S+Ph2・TfO
-
F
+          RNH2
1 6a (72%)
6b (46%)
N
F
R
R= Ts (a)
= PhCH2CH2 (b)  
Scheme 2. Synthesis of 2-fluoroaziridine 6 
 
 
4.3. Conclusion 
 
In summary, the author has successfully developed a new mono-fluorinated vinyl 
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sulfonium salt 1 in one step and demonstrated its high performance for the synthesis of 
mono-fluorinated cyclopropanes and aziridines under mild conditions.  
 
 
4.4. Experimental 
 
4.4.1. General information 
1
H, 
13
C, and 
19
F NMR spectra were measured in CDCl3 and/or DMSO-d6 solutions, 
unless otherwise stated.  Chemical shifts were given by δ relative to that of an internal 
Me4Si (TMS) for 
1
H NMR and 
13
C NMR spectra.  On the other hand, chemical shifts 
were given by δ relative to that of CFCl3 for 
19
F NMR spectra using an internal 
CF3C6H5 (benzotrifluoride) or C6F6.  Infrared (IR) spectra are reported in cm
-1
.  
Melting points are uncorrected.  
 
4.4.2. Preparation of 1 
A 25 mL two-necked flask equipped with a magnetic stir bar, a stopcock and a 
three-way stopcock was charged with (-fluorovinyl)phenylsulfide 3 (82.0 mg, 0.532 
mmol, 1.0 equiv.) in 1 mL of 1,2-dichloroethane (CH2ClCH2Cl) under argon.  To this 
solution was added diphenyliodonium triflate (212.0 mg, 0.506 mmol, 0.95 equiv.) and 
Cu powder (174.0 mg, 2.67 mmol, 5.0 equiv.).  The reaction mixture was refluxed for 
30 min.  After cooling to room temperature, the mixture was directly purified by silica 
gel chromatography (CH2Cl2 then CH2Cl2/acetone = 10/1–2/1) to give the desired 
product 1 as a white solid (129.0 mg, 67 %). 
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4.4.3. Preparation of 5a 
A 25 mL two-necked flask equipped with a magnetic stir bar, a stopcock and a 
three-way stopcock was charged with phenylsulfonylacetonitrile 4a (39.9 mg, 0.22 
mmol. 1.0 equiv.) and DBU (39 μL, 0.261 mmol, 1.2 equiv.) in acetonitrile (1 mL) 
under argon.  After stirring for 5 min, to this solution was added the salt 1 (99.4 mg, 
0.261 mmol, 1.2 equiv.).  The reaction mixture was stirred at room temperature for 30 
min.  The reaction was quenched with a saturated aqueous NH4Cl solution and 
extracted with hexane/AcOEt = 1/1.  The extraction was repeated twice.  The 
combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure.  The residue was purified by silica gel column chromatography 
(hexane/AcOEt = 5/1–1/1) to give the desired product 5a as a white solid (46.0 mg, 
93 %). 
 
4.4.4. Preparation of 6a 
A 25 mL two-necked flask equipped with a magnetic stir bar, a stopcock and a 
three-way stopcock was charged with p-toluenesulfonamide (33.0 mg, 0.193 mmol, 1.0 
equiv.) in 1 mL of THF under argon.  To this solution was added NaH (67.2 % oil 
dispersion, 35.0 mg, 0.234 mmol, 1.2 equiv.) and the mixture was stirred for 15 min.  
To the resulting solution was added the salt 1 (78.0 mg, 0.205 mmol, 1.05 equiv.).  
After the reaction mixture was stirred at room temperature for 30 min, the reaction was 
quenched with saturated aqueous NaHCO3 solution.  After the organic layer was 
separated, additional extraction with hexane/AcOEt = 3/1 was repeated twice.  The 
combined organic solution was dried over Na2SO4.  The solution was concentrated in 
vacuo and the residual oil was purified by silica gel chromatography (hexane/AcOEt = 
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3/1) to give the desired product 6a as a white solid (29.8 mg, 72 %). 
 
4.4.5. Preparation of 6b 
A 25 mL two-necked flask equipped with a magnetic stir bar, a stopcock and a 
three-way stopcock was charged with β-phenethylamine (44.1 L, 0.350 mmol, 1.0 
equiv.) in 1 mL of DMSO under argon.  To this solution was added tBuNH2 (110 L, 
1.05 mmol, 3.0 equiv.) and the salt 1 (146 mg, 0.385 mmol, 1.1 equiv.).  After the 
reaction mixture was stirred at room temperature for 5 h.  The reaction was quenched 
with water and extracted with ether.  The combined organic solution was dried over 
Na2SO4.  The solution was concentrated in vacuo and the residual oil was purified by 
silica gel chromatography (hexane/ether = 2/1) to give the desired product 6b as a 
colorless oil (27.1 mg, 48 %). 
 
4.4.6. Data of products (1, 5a–5i, 6a) 
-Fluorovinyl)-diphenyl-sulfonium trifluoromethanesulfonate (1)  
white solid; yield 67 %; mp: 71.0–72.0 ℃; IR (KBr) 3128, 3047, 2996, 1645, 1579, 
1478, 1452, 1265, 1143, 1028, 944, 749, 683, 637, 572, 548, 517, 486 cm
-1
; 
1
H NMR 
(CDCl3, 400 MHz) δ 7.91 (d, J = 8.0 Hz, 4H), 7.83 (t, J = 7.3 Hz, 2H), 7.76–7.71 (m, 
4H), 6.60 (dd, J = 42.7, 6.0 Hz, 1H), 6.14 (dd, J = 10.9, 6.0 Hz, 1H); 
13
C NMR (CDCl3, 
101 MHz) δ 146.0 (d, J = 315.3 Hz), 135.2, 131.6, 130.8, 121.2, 120.5 (q, J = 320.7 Hz), 
114.9 (d, J = 7.8 Hz); 
19
F NMR (CDCl3, 376 MHz) δ –79.6 (s, 3F) –104.7 (dd, J = 42.7, 
10.9 Hz); Anal. Calcd. for C15H12F4O3S2: C, 47.36, H, 3.18; Found: C, 47.34, H, 3.14. 
 
2-Fluoro-1-(phenylsulfonyl)cyclopropanecarbonitrile (5a) 
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White solid; yield 93 %; dr: 95/5; mp: 99.5–110.1 ℃; IR (ATR) 3111, 3021, 2245, 
1583, 1450, 1422, 1327, 1306, 1180, 1155, 856, 723, 684 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) δ 7.99 (d, J = 7.2 Hz, 2H), 7.81 (t, J = 7.2 Hz, 1H), 7.68 (t, J = 7.2 Hz, 2H), 5.26 
(dt, J = 60.8, 5.5 Hz, 1H), 2.39–2.20 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ 136.2, 
135.5, 129.9, 128.8, 111.9 (d, J = 3.9 Hz), 72.8 (d, J = 248.3 Hz), 37.0 (d, J = 10.1 Hz), 
21.5 (d, J = 9.4 Hz); 
19
F NMR (CDCl3, 376 MHz) δ –207.2 (ddd, J = 60.8, 19.1, 13.2 
Hz); GC-MS (EI, m/z, 70 eV) 225 (53, M
+
), 160 (4), 141 (26), 125 (18), 109 (4), 97 (4), 
77 (100), 73 (9), 65 (2), 51 (25); Anal. Calcd. for C10H8FNO2S: C, 53.32; H, 3.58; N, 
6.22. Found: C, 53.36; H, 3.38; N, 6.21. 
 
2-Ethoxyethyl 1-cyano-2-fluorocyclopropanecarboxylate (5b) 
Colorless oil; yield 98 %; dr: 91/9; IR (ATR) 2978, 2873, 2253, 1737, 1377, 1302, 1269, 
1121, 882, 859 cm
-1
; 
1
H NMR (CDCl3, 400 MHz)δ 5.02 (ddd, J = 62.0, 5.8, 4.5 Hz, 
1H), 4.39–4.31 (m, 2H), 3.71–3.66 (m, 2H), 3.56 (q, J = 6.9 Hz, 2H), 2.14 (ddd, J = 
21.3, 7.4, 4.3 Hz, 1H), 2.03 (ddd, J = 15.5, 7.4, 5.8 Hz, 1H), 1.22 (t, J = 6.9 Hz, 3H); 
13
C NMR (CDCl3, 101 MHz)δ 165.3, 113.8 (d, J = 3.8 Hz), 75.1 (d, J = 244.5 Hz), 67.5, 
66.7, 66.3, 23.6 (d, J = 7.8 Hz), 19.7 (d, J = 10.9 Hz), 15.0; 
19
F NMR (CDCl3, 376 
MHz)δ –204.7 (ddd, J = 62.0, 21.3, 15.5 Hz); GC-MS (EI, m/z, 70 eV) 172 , (1, M+–Et), 
156 (47), 142 (5), 129 (8), 112 (67), 98 (4), 84 (31), 72 (25), 59 (100). 
 
1-Cyano-2-fluorocyclopropanecarboxamide (5c) 
White solid; yield 79 %; dr: 98/2; mp: 120 °C (sublimation); IR (KBr) 3407, 3211, 3124, 
2249, 1667, 1436, 1402, 1282, 1203, 1146, 1068, 1053, 1030, 876, 752, 675 cm
-1
; 
1
H 
NMR (CDCl3, 400 MHz)δ 6.43 (bs, 1H), 5.77 (bs, 1H), 5.01 (ddd, J = 62.4, 5.1, 4.7 Hz, 
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1H), 2.20–2.00 (m, 2H); 13C NMR (DMSO-d6, 101 MHz)δ 164.8, 116.4 (d, J = 4.7 Hz), 
75.2 (d, J = 237.4 Hz), 21.9 (d, J = 8.5 Hz), 20.0 (d, J = 9.4 Hz); 
19
F NMR (CDCl3, 376 
MHz)δ 206.5 (ddd, J = 62.4, 22.7, 16.7 Hz); Anal. Calcd. for C5H5FN2O: C, 46.88; H, 
3.93; N, 21.87. Found: C, 47.01; H, 3.84; N, 21.84. 
 
Diethyl 1-cyano-2-fluorocyclopropylphosphonate (5d) 
Colorless oil; yield 70 %; dr: 91/9; IR (ATR) 2987, 2243, 1443, 1367, 1258, 1189, 1012, 
860, 800, 731 cm
-1
; 
1
H NMR (CDCl3, 400 MHz)δ 5.04, (dddd, J = 62.0, 9.4, 5.6, 3.9 
Hz, 1H), 4.33–4.18 (m, 4H), 2.08–1.92 (m, 1H), 1.92–1.78 (m, 1H), 1.44 (t, J = 6.9 Hz, 
3H), 1.41 (t, J = 6.9 Hz 3H); 
13
C NMR (CDCl3, 101 MHz)δ 114.3 (d, J = 6.2 Hz), 72.3 
(d, J = 242.9 Hz), 64.3 (t, J = 6.2 Hz), 19.4 (dd, J = 10.2, 3.8 Hz), 16.2 (d, J = 3.1 Hz), 
16.3 (d, J = 2.3 Hz), 11.3 (dd, J = 193.0, 10.1 Hz); 
19
F NMR (CDCl3, 376 MHz)δ 208.8 
(dddd, J = 62.0, 20.3, 13.1, 3.6 Hz); GC-MS (EI, m/z, 70 eV) 206 (2, M
+–Me), 193 (5), 
178 (2), 165 (100), 145 (49), 117 (7), 109 (4), 107 (5), 81 (14), 65 (8). 
 
tert-Butyl 1-acetyl-2-fluorocyclopropanecarboxylate (5e) 
yield 79 %; dr: 72/28 
5ea (major, less polar); Colorless oil; IR (NaCl) 2981, 1725, 1699, 1245, 1369, 1325, 
1262, 1215, 1174, 1146, 1115 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 4.94 (dm, J = 65.1 
Hz, 1H), 2.43 (s, 3H), 2.14 (dm, J = 22.1 Hz, 1H), 1.65–1.45 (m, 1H), 1.52 (s, 9H); 13C 
NMR (CDCl3, 101 MHz) 201.3, 165.0, 82.9, 77.2 (d, J = 237.4 Hz) , 42.4, 27.9, 22.3 
(d, J = 7.8 Hz); 
19
F NMR (CDCl3, 376 MHz) –212.6 (ddd, J = 65.1, 22.1, 14.4 Hz). 
GC-MS (EI, m/z, 70 eV) 146 (51), 129 (57, M
+–OtBu), 141 (26), 101 (2), 87 (28), 81 
(11), 70 (2), 57 (100). 
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5eb (minor, more polar); Colorless oil; IR (NaCl) 2980, 2935, 1712, 1425, 1370, 1302, 
1168, 1120, 1071cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 4.99 (dm, J = 62.6 Hz, 1H), 2.42 
(s, 3H), 2.18 (dm, J = 22.6 Hz), 1.55–1.45 (m, 1H) 1.48 (s, 9H); 13C NMR (CDCl3, 101 
MHz) 83.0, 75.5 (d, J = 232.8 Hz), 30.4, 28.0, 18.4 (d, J = 8.8 Hz), three carbon was 
lost; 
19
F NMR (CDCl3, 376 MHz) –215.2 (ddd, J = 62.6, 22.6, 13.1 Hz). GC-MS (EI, 
m/z, 70 eV) 146 (37), 129 (39, M
+–OtBu), 87 (20), 81 (7), 57 (100). 
 
Methyl 2-fluoro-1-(phenylsulfonyl)cyclopropanecarboxylate (5f) 
yield 83 %; dr: 50/50 
5fa (less polar); White solid; mp: 74.0–75.0 °C; IR (KBr) 3131, 3073, 3042, 2964, 1746, 
1450, 309, 1228, 1162, 1161, 1121, 1073, 1013, 960, 885, 819, 735, 683 cm
-1
; 
1
H NMR 
(CDCl3, 400 MHz)δ 7.99–7.94 (m, 2H), 7.71–7.67 (m, 1H), 7.62–7.56 (m, 2H), 5.28 
(ddd, J = 63.8, 7.0, 4.7 Hz, 1H), 3.73 (s, 3H), 2.51 (ddd, J = 20.2, 7.9, 4.7 Hz, 1H), 2.32 
(ddd, J = 12.9, 7.9, 7.0 Hz, 1H); 
13
C NMR (CDCl3, 101 MHz)δ 162.5, 138.9, 134.2, 
129.2, 128.9, 74.7 (d, J = 245.2 Hz), 53.2, 49.4 (d, J = 10.9 Hz), 19.7 (d, J = 9.3 Hz); 
19
F NMR (CDCl3, 376 MHz)δ –214.1 (ddd, J = 63.8, 20.2, 12.9 Hz); GC-MS (EI, m/z, 
70 eV) 258 (14, M
+
), 227 (22), 194 (8), 162 (28), 141 (22), 134 (25), 125 (24), 117 (33), 
87 (12), 77 (100), 63 (29), 59 (15), 51 (31). 
5fb (more polar); Colorless oil (81 % pure); IR (NaCl) 3070, 2958, 1743, 1448, 1329, 
1285, 1170, 1135, 1082, 952, 895, 812, 688 cm
-1
; 
1
H NMR (CDCl3, 400 MHz)δ 8.06 (d, 
J = 8.0 Hz, 2H), 7.70–7.61 (m, 1H), 7.61–7.54 (m, 2H), 4.89 (ddd, J = 64.2, 6.3, 4.9 Hz, 
1H), 3.67 (s, 3H), 2.88 (ddd, J = 21.5, 7.6, 4.9 Hz, 1H), 2.16 (ddd, J = 13.2, 7.6, 6.3 Hz, 
1H); 
13
C NMR (CDCl3, 101 MHz)δ 165.1, 139.5, 134.3, 133.9, 128.7, 75.8 (d, J = 
247.6 Hz), 53.1, 48.0 (d, J = 11.6 Hz), 19.75 (d, J = 8.5 Hz); 
19
F NMR (CDCl3, 376 
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MHz)δ –211.7 (ddd, J = 64.2, 21.5, 13.2 Hz); GC-MS (EI, m/z, 70 eV) 258 (42, M+), 
227 (16), 194 (5), 162 (14), 141 (22), 134 (24), 125 (32), 117 (19), 87 (8), 77 (100), 63 
(19), 59 (13), 51 (30). 
 
Dibenzyl 2-fluorocyclopropane-1,1-dicarboxylate (5g) 
Colorless oil; yield 77 %; IR (ATR) 3035, 1723, 1311, 1277, 1210, 1118, 1073, 1025, 
903, 734, 695 cm
-1
; 
1
H NMR (CDCl3, 400 MHz)δ 7.36–7.21 (m, 10H), 5.29–4.99 (m, 
5H), 2.23 (ddd, J = 22.3, 7.2, 4.1 Hz, 1H); 
13
C NMR (CDCl3, 101 MHz)δ 167.6 , 164.3 
(d, J = 3.1 Hz), 128.6 , 128.5, 128.4, 128.3, 128.13, 128.07, 75.1 (d, J = 235.9 Hz), 67.9, 
67.5, 34.4 (d, J = 12.5 Hz), 20.3 (d, J = 9.4 Hz); 
19
F NMR (CDCl3, 376 MHz)δ 213.1 
(ddd, J = 64.4, 22.3, 14,3 Hz); GC-MS (EI, m/z, 70 eV) 237 (7, M
+–Bn), 219 (5), 184 
(5), 180 (5), 171 (6), 131 (30), 107 (42), 91 (100), 65 (12). 
 
1-(2-Fluoro-1-(phenylsulfonyl)cyclopropylsulfonyl)benzene (5h) 
White solid; yield 93 %; mp: 87.0–88.2 °C; IR (ATR) 3107, 3072, 1583, 1449, 1419, 
1330, 1236, 1175, 1150, 1078, 979, 883, 801, 751, 729, 715, 685, 637 cm
-1
; 
1
H NMR 
(CDCl3, 400 MHz)δ 8.08–8.04 (m, 2H), 8.01–7.96 (m, 2H), 7.76–7.67 (m, 2H), 
7.62–7.54 (m, 4H), 5.51 (ddd, J = 64.2, 6.8, 4.7 Hz, 1H), 2.91 (ddd, J = 20.1, 8.6, 4.7 
Hz, 1H), 2.07 (ddd, J = 12.5, 8.6, 6.8 Hz, 1H); 
13
C NMR (CDCl3, 101 MHz)δ 138.7, 
137.6, 134.7 , 134.5, 123.0, 129.8, 129.7, 129.0, 128.7, 73.5 (d, J = 248.3 Hz), 61.0 (d, J 
= 10.9 Hz), 20.0 (d, J = 10.2 Hz); 
19
F NMR (CDCl3, 376 MHz)δ 214.6 (ddd, J = 64.2, 
20.1, 12.5 Hz); GC-MS (EI, m/z, 70 eV) 232 (5), 167 (1), 141(27), 139 (7), 125 (11), 
107 (65), 91 (47), 77 (100), 51 (26). 
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1-Fluoro-5,7-dimethyl-5,7-diazaspiro[2.5]octane-4,6,8-trione (5i) 
Whit solid; yield 96 %; mp: 88.5–90.2 °C; IR (KBr) 3114, 3073, 2963, 2533, 1746, 
1681, 1470, 1385, 1293, 1176, 1131, 1070, 1038, 852, 757 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz)δ 5.05 (ddd, J = 64.4, 6.1, 5.2 Hz, 1H), 3.37 (s, 3H), 3.33 (s, 3H), 2.70 (ddd, J = 
21.5, 6.1, 5.2 Hz, 1H), 2.29 (dt, J = 14.8, 6.1 Hz, 1H); 
13
C NMR (CDCl3, 101 MHz)δ 
166.4, 163.1, 151.5, 81.5 (d, J = 254.5 Hz), 33.2 (d, J = 10.1 Hz), 28.8, 28.6, 24.5 (d, J 
= 7.0 Hz); 
19
F NMR (CDCl3, 376 MHz)δ 206.3 (ddd, J = 64.4, 21.5, 14.8 Hz); Anal. 
Calcd. for C8H9FN2O3: C, 48.00; H, 4.53; N, 14.00. Found: C, 48.09; H, 4.49; N, 13.90. 
 
2-Fluoro-N-tosylaziridine (6a) 
Whit solid; yield 71 %; mp: 56.9–57.5 ℃; IR (KBr) 3077, 1595, 1448, 1381, 1324, 
1254, 1168, 1124, 1095, 1061, 974, 882, 812, 731, 674, 573 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz)δ 7.86 (d, J = 8.1 Hz, 2H), 7.38 (d, J = 8.1 Hz, 2H), 5.40 (ddd, J = 72.2, 2.4, 2.2 
Hz, 1H), 2.80–2.75 (m, 1H), 2.71–2.68 (m, 1H), 2.45 (s, 3H); 13C NMR (CDCl3, 101 
MHz)δ 145.3, 134.3, 129.9, 127.9, 76.7 (d, J = 255.3 Hz), 34.0 (d, J = 13.3 Hz), 21.6; 
19
F NMR (CDCl3, 376 MHz)δ –178.3 (d, J = 72.2 Hz); GC-MS (EI, m/z, 70 eV) 215 (2 
M
+
), 184 (66), 155 (91), 139 (2), 107 (2), 91 (100), 77 (3), 65 (23); Anal. Calcd. for 
C9H10FNO2S: C, 50.22; H, 4.68; N, 6.51. Found: C, 50.39; H, 4.73; N, 6.50. 
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Chapter five 
Diethylzinc-Promoted Synthesis of CF3-containing Tryptamine 
Analogues from Indoles and 2-CF3-N-Ts-Aziridine 
 
 
5.1. Introduction 
 
A component of several classes of bioactive natural compounds includes the indole 
framework.
1
  On the other hand, introduction of β-aminoethyl group at the C-3 
position of the indole ring brings us to the tryptamine family, which includes melatonin 
and serotonin.
2
  Considering the promising effect of the existence of fluorine atom in 
bioactive molecules, introduction of a trifluoromethyl group into the indole side chain 
may enhance their highly beneficial effects for medical treatment.  The simple and 
effective modification of bioactive tryptamines remains an important task in modern 
organic chemistry.  The author’s literature research revealed that there are only a few 
reports on the modification of tryptamines containing a trifluoromethyl group (CF3) in 
the side chain.  Among these, there are few reports about β-CF3-tryptamine.
3
  As 
mentioned above, fluoro substituents are powerful modifiers of the chemical and 
biological properties of organic compounds.  There are many related reports found in 
pharmaceuticals and agrochemicals.
4
  Therefore, it is an important objective to develop 
a facile method for the synthesis of a trifluoromethylated tryptamine.  From a synthetic 
viewpoint, the most direct method seems to synthesize the tryptamine from an indole 
and a 2-(trifluoromethyl)aziridine derivative (Scheme 1).
5  
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Scheme 1. Structures of tryptamines
 
 
 
5.2. Results and discussion 
 
  There are many reports using this methodology with fluorine-free aziridines and 
indoles under several Lewis acidic conditions to give the corresponding ring-opening 
product.
6
  However, the above fluorine-free aziridines almost always possess an 
electron-donating group in the aziridine ring.  At any rate, our preliminary attempts 
with indole and 2-CF3-N-Ts-aziridine 1 in the presence of AgSbF6 or BF3OEt2 resulted 
in the quantitative recovery of both starting materials.  These finding suggested the 
negative effect of the existence of electron-withdrawing group retarded the ring-opening 
reaction in our case.  Then the author turned my attention to the execution of the 
reaction under Lewis basic conditions.  Unlike Lewis acidic conditions, reports of the 
reaction under Lewis basic conditions are few.
3c,7
  One of the main shortcomings of 
this transformation appears to be low product yields.   
 During the course of our group efforts to explore the synthetic utilization of 
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2-CF3-N-Ts-aziridine 1,
8
 our group have recently reported the regioselective 
ring-opening reaction of 1 with some nucleophiles under basic conditions.
9
  In this 
study, we carried out the reaction of 1 with an indole in the presence of tBuOK as a base 
under basic conditions to obtain the corresponding N-1 adduct of the indole in excellent 
yield with complete regioselectivity (Table 1, entry 10).  The author got the hint of the 
solution of own problem.  If this ring-opening reaction proceeds smoothly at the C-3 
position of the indole, it could provide a solution for the synthesis of CF3-containing 
tryptamine analogues.  The author considered that the difference between N-alkylation 
and C–alkylation must be attributed to the HSAB theory.  The author discloses the first 
diethylzinc-promoted direct C-3 alkylation of indoles with 1 under basic conditions.  
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Table 1. Optimization of the reaction conditions
a
 
N
Ts
CF3
N
H
+
N
H
NHTs
CF3
N
NHTs
CF3
+
1 2a 3a 4a
base
solvent, temp.
 
entry 
 
2a  
(equiv.) 
base 
(equiv.) 
solvent 
 
temp.  
(℃)  
time  
(h)  
yield (%)
b
 
3a 4a 
1 2.0  none toluene 100  48  NR
c
 
2 2.0  Et2Zn (2.0) toluene 25  24  NR
c
 
3 2.0  Et2Zn (2.0) toluene 100  24  quant 0 
4 1.3  Et2Zn (1.3) toluene 100  17  quant
d
 0 
5 1.3  Et2Zn (1.3) 1,4-dioxane 100  24  quant 0 
6 1.3  Et2Zn (1.3) toluene 80  72  93 0 
7 1.3  Et2Zn (0.6) toluene 100  72  52 0 
8 1.3  Et2Zn (0.2) toluene 100  72  trace 0 
9 1.1  NaH (1.1) DMSO 25  1  0 quant 
10
e
 1.1  tBuOK (1.1) DMSO 25  1  0 quant
f
 
a
 1 (0.23 mmol, 1.0 equiv.) and Et2Zn (1.06 M in hexane) were used.  
b
 GC-MS yield.   
c
 No reaction.  
d
 99 % isolated yield.  
e
 See Ref. 9.  
f
 98 % isolated yield.        .  
 
The author selected indole 2a in order to examine the diethylzinc-promoted 
ring-opening model reaction.
10
  When two equivalents of 2a and diethylzinc were 
treated with one equivalent of 1 in toluene at 25 °C, no reaction took place, even after 
24 h (entry 2).  Then the author tried this reaction under more harsh conditions.  
Fortunately, when the same reaction was just heated to 100 °C, the desired ring-opening 
 83 
product 3a was obtained with excellent regioselsectivity in quantitative yield (entry 3). 
This is the first successful example of the ring-opening reaction of aziridine with an 
indole promoted by a zinc reagent.  Encouraged by this promising result, the author 
continued to optimize the reaction conditions.  Even if was reduced the amount of 
indole and diethylzinc down to 1.3 equivalents from 2.0 equivalents, no detrimental 
effects were observed (entry 4).  In addition to toluene solvent, the use of 1,4-dioxane 
essentially tolerated the reaction (entry 5).  Lowering the reaction temperature required 
prolonged reaction times (entry 6).  Decreasing the amount of diethlyzinc (0.6 equiv.) 
relative to the indole caused an incomplete reaction (entry 7).  This finding suggested 
that the stoichiometric amount of diethylzinc is necessary for the successful reaction and 
this reaction did not proceed with a catalytic amount of diethylzinc.  The use of a 
different base (NaH) gave a complete reversal of the regioselectivity, yielding 4a in 
quanititative yield (entry 9).  The author produced the single crystals of adduct 3a 
suitable for X-ray crystallographic analysis.  The ORTEP drawing of 3a is shown in 
Figure 1.
11
  The author obtained unambiguous proof of the regiochemistry of the C-3 
substitution of the indole. 
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H
NHTs
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Figure 1. ORTEP drawing of the adduct 3a with thermal ellipsoids shown at 50% probability 
level 
 
Having finished the optimal reaction conditions for the synthesis of CF3-tryptamine 3a 
(Table 1, entry 4), the author subsequently explored the substrate scope of this 
transformation with respect to commercially available indoles and their derivatives.  
Table 2 shows that most indoles took part in this nucleophilic substitution reaction at C3 
position to give the corresponding CF3-trypramines in excellent yields and complete 
regioselectivity.  Electron-donating (OMe, OBn, OTBDMS, Ph, Me) and 
electron-withdrawing (Br, CO2Me, CN) substituents at the C-5, C-4, and C-2 positions 
of the indoles were compatible with this transformation.  Among them, 5-cyanoindole 
was a reluctant nucleophile, its reaction resulted in an incomplete reaction along with 
the recovery of unreacted aziridine 1 under the same reaction conditions.  To overcome 
this difficulty, the author used a larger amount of indole (2.3 equiv.) and diethylzinc (2.3 
equiv.) in chlorobenzene/THF = 10/1 at 130 °C for 54 h; however, the satisfactory 
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conversion of 1 did not occur (entry 6).  Unfortunately, when the author employed 
4-hydroxyindole for this reaction, no ring-opening reaction occurred, and both starting 
materials were recovered although the author used twice the amount of diethylzinc (2.6 
equiv.).  At the present time, the reason for this unsuccessful reaction is unclear.  
Moreover, it is noteworthy that N-methyl indole did not participate in this reaction; the 
free NH group of the indole ring is essential for this transformation (entry 12). 
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Table 2. Substrate scope for the synthesis of CF3-tryptamines
a
  
N
H
R
N
H
R
NHTs
CF3
N
Ts
CF3
+
1 2 3
Et2Zn (1.3 equiv.)
toluene, temp.
 
entry 2 R temp. (℃) time (h) 3 yieldb (%) 
1 2a H 100 17 3a 99 
2 2b 5-OMe 100 15 3b 98 
3 2c 5-OBn 100 19 3c 99 
4 2d 5-Br 100 14 3d 99 
5
c
 2e 5-COOMe 130 12 3e 94 
6
d
 2f 5-CN 130 54 3f 76 (94) 
7
e
 2g 4-OMe 100 20 3g 99 
8 2h 4-OTBDMS 100 7 3h 99 
9 2i 4-OH 100 24 3i NR
f
 
10 2j 2-Ph 100 10 3j 97 
11 2k 2-Me 100 11 3k 99 
12 2l 1-Me 100 24 3l NR
f
 
a
 The reaction of 1 (1.0 equiv.) with indoles 2 (1.3 equiv.) was carried out. 
b
 Isolated yield.  
c
 The reaction of 1 (1.0 equiv.) with indole 2e (2.3 equiv.) was 
conducted in the presence of Et2Zn (2.3 equiv.) in chlorobenzene.  
d
 The reaction 
of 1 (1.0 equiv.) with indole 2f (2.3 equiv.) was conducted in the presence of Et2Zn 
(2.3 equiv.) in chlorobenzene/THF = 10/1.  
e
 The reaction was conducted in 
chlorobenzene at 100 °C.  
f  
No reaction.                            . 
 
Finally, deprotection of the NH-Ts group to give free NH2 was examined.  This 
deprotection often encountered the difficulty.  The author referred to the procedure 
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reported by Okamoto et al..  Thus the adduct 3a was exposed to reductive cleavage 
conditions.
12
  Although the reaction was sluggish, the corresponding free 
NH2-CF3-tryptamine 5a was obtained in 61 % yield (Scheme 2). 
 
N
H
NHTs
CF3
3a
N
H
NH2
CF3
5a (61%)
Mg (10 equiv.) 
Ti(OiPr)4 (2.0 equiv.)
Me3SiCl (3.0 equiv.)
THF, 50℃, 40h
 
Scheme 2. Deprotection of 3a to give 5a 
 
 
5.3. Conclusion 
 
In conclusion, the author has developed the synthesis of CF3-tryptamine from 1 and 
indoles using diethylzinc (Et2Zn) as a base with excellent yields and complete 
regioselectivity.  It is noteworthy that this reaction has its simplicity, practicality, and 
broad functional group tolerance.  Further efforts to transform the adducts into 
analogous biologically active molecules are underway in our laboratory. 
 
 
5.4. Experimental 
 
5.4.1. General information 
1
H, 
13
C, and 
19
F NMR spectra were measured in CDCl3 and/or DMSO-d6 solutions, 
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unless otherwise stated.  Chemical shifts were given by δ relative to that of an internal 
Me4Si (TMS) for 
1
H NMR and 
13
C NMR spectra.  On the other hand, chemical shifts 
were given by δ relative to that of CFCl3 for 
19
F NMR spectra using an internal 
CF3C6H5 (benzotrifluoride) or C6F6.  Infrared (IR) spectra are reported in cm
-1
.  
Melting points are uncorrected.  
 
5.4.2. Preparation of 3a 
A 25 mL two-neck flask equipped with a magnetic stir bar, a stopcock and, a three-way 
stopcock was charged with 1 mL of toluene under argon.  To this solution was 
successively added indole 2a (34.4 mg, 0.294 mmol, 1.3 equiv.), 2-CF3-N-Ts-aziridine 1 
(60.0 mg, 0.226 mmol, 1.0 equiv.), and Et2Zn (1.06 M in hexane solution, 0.28 L, 1.3 
equiv.).  After the mixture was stirred for 5 min at room temperature, the flask was 
immersed in a preheated (100 °C) oil bath and stirred at this temperature for 17 h until 
the complete consumption of 1 (checked by TLC and GC-MS).  After the reaction 
mixture was cooled to room temperature, to the mixture was added a saturated aqueous 
solution of NH4Cl (3 mL), and the resulting mixture was extracted with EtOAc (2 mL) 
three times.  The combined organic fractions were dried over sodium sulfate. To this 
solution was added a spoonful of silica gel, and the resulting suspension was carefully 
concentrated in vacuo.  The residue was purified by chromatography on a silica gel 
column (hexane/EtOAc = 20/1 then 1/1 as an eluent) to give 3a (85.9 mg, 99 %) as a 
pale pink solid.   
 
5.4.2. Preparation of 5a
3c
 
A 25 mL two-neck flask equipped with a magnetic stir bar, a stopcock and a three-way 
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stopcock was charged with Mg turnings (62.3 mg, 2.56 mmol, 10.0 equiv).  This flask 
was heated by a heat-gun under vacuo for 15 min.  After the flask was cooled to room 
temperature, to the flask was successively added THF (2 mL), Me3SiCl (0.1 mL, 0.788 
mmol, 3.0 equiv.), Ti(OiPr)4 (0.15 mL, 0.507 mmol, 2.0 equiv.), and 3a (101.3 mg, 
0.265 mmol, 1.0 equiv.) under argon.  The mixture was stirred at 50 °C for 40 h.  
After cooling to room temperature, to the mixture was successively added an aqueous 
2M-NaOH solution (0.2 mL), ether (10 mL), Celite (0.5 g), and NaF (0.5 g).  After the 
resulting suspension was stirred for 1 h, the mixture was filtered through a pad of Celite. 
The pad of Celite was washed with ether (10 mL) and to the combined filtrate was 
added an aqueous 2M-NaOH solution (5 mL).  After the mixture was stirred for 1 h, 
the organic layer was separated.  The aqueous layer was extracted with ether (5 mL x 
3), and the combined organic fractions were dried over Na2SO4, and then concentrated 
in vacuo.  The residue was purified by chromatography on a silica gel column NH 
(Chromatorex, Fuji Silysia, hexane/AcOEt = 1/1) to give the desired product 5a as a 
white solid (36.7 mg, 61 %). 
 
5.4.3. Characteristic spectroscopic data of products (3a-3h, 3j and 3k, 5a) 
N-[3-(1H-indol-3-yl)-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfonamide (3a) 
Pink solid; yield 99 %; mp: 170.3–170.5 °C; IR (KBr) 3410, 3273, 2930, 1599, 1458, 
1270, 1175, 1120, 949, 805, 666, 576 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 7.96 (s, 1H), 
7.43–7.38 (m, 3H), 7.31–7.26 (m, 1H), 7.22–7.16 (m, 1H), 7.19 (t, J = 7.4 Hz, 1H), 
7.01–6.98 (m, 3H), 4.88 (d, J = 8.6 Hz, 1H), 4.29–4.18 (m, 1H), 3.26 (dd, J = 15.0, 3.9 
Hz, 1H), 2.97 (dd, J = 15.0, 8.6 Hz, 1H), 2.33 (s, 3H); 
13
C NMR (CDCl3/DMSO-d6 = 
4/1, 101 MHz)  140.9, 136.7, 135.3, 127.5, 125.5, 124.6, 124.1 (q, J = 283.2 Hz), 
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123.3, 119.9, 117.5, 116.4, 110.4, 106.5, 54.3 (q, J = 29.0 Hz), 23.2, 20.3; 
19
F NMR 
(CDCl3, 376 MHz)  –76.3 (d, J = 6.4 Hz); GC-MS (EI, m/z, 70 eV) 382 (7, M
+
), 226 
(1), 211 (3), 130 (100), 103 (4), 91 (8), 77 (5), 65 (3), 51 (1); Anal. Calcd. for 
C18H17F3N2O2S: C, 56.54; H, 4.48; N, 7.33. Found: C, 56.54; H, 4.57; N, 7.24. 
 
N-[3-{5-methoxy-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfon
amide (3b) 
White solid; yield 98 %; mp: 172.5–173.5 °C; IR (KBr) 3414, 3396, 3290, 2975, 2929, 
1587, 1333, 1262, 1172, 1113, 1027, 946, 797, 563, 545 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) 7.90 (s, 1H), 7.45 (d, J = 7.4 Hz, 2H), 7.19 (d, J = 8.6 Hz, 1H), 7.04 (d, J = 7.4 
Hz, 2H), 6.99 (s, 1H), 6.90 (s, 1H), 6.86 (d, J = 8.6 Hz, 1H), 4.85 (d, J = 8.6 Hz, 1H), 
4.27–4.12 (m, 1H), 3.86 (s, 3H), 3.25 (dd, J = 14.9, 3.9 Hz, 1H), 2.98 (dd, J = 14.9, 7.6 
Hz, 1H), 2.34 (s, 3H); 
13
C NMR (CDCl3/CD3OD = 4/1, 101 MHz) 153.5, 142.5, 136.9, 
131.5, 128.6, 126.9, 125.7, 124.7 (q, J = 282.7 Hz), 124.6, 111.9, 111.4, 107.4, 99.7, 
55.7, 55.3 (q, J = 29.4 Hz), 24.4, 21.0; 
19
F NMR (CDCl3, 376 MHz) –75.9 (d, J = 7.1 
Hz); GC-MS (EI, m/z, 70 eV) 412 (9, M
+
), 241 (2), 160 (100), 145 (10), 117 (6), 91 (8), 
65 (2); Anal. Calcd. for C19H19F3N2O3S: C, 55.33; H, 4.64; N, 6.79. Found: C, 55.09; H, 
4.72; N, 6.75. 
 
N-[3-{5-benzyloxy-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfo
namide (3c) 
Pale pink solid; yield 99 %; mp: 139.9–140.5 °C; IR (KBr) 3430, 3405, 3257, 2922, 
2875, 1585, 1486, 1456, 1334, 1272, 1173, 1120, 1092, 1057, 944, 845, 742, 671, 570 
cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 7.85 (s, 1H), 7.50 (d, J = 8.0 Hz, 2H), 7.44–7.30 
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(m, 5H), 7.16 (d, J = 8.5 Hz, 1H), 6.97–6.90 (m, 5H), 5.11 (s, 2H), 4.94 (d, J = 8.8 Hz, 
1H), 4.19–4.05 (m, 1H), 3.21 (dd, J = 15.1, 4.3 Hz, 1H), 2.91 (dd, J = 15.1, 8.5 Hz, 1H), 
2.30 (s, 3H); 
13
C NMR (CDCl3, 101 MHz) 153.1, 143.1, 137.5, 136.2, 131.4, 129.0, 
128.5, 127.9, 127.6, 127.0, 126.2, 124.7, 124.7 (q, J = 282.6 Hz), 112.9, 112.0, 107.3, 
101.6, 70.9, 55.0 (q, J = 29.5 Hz), 24.7, 21.4; 
19
F NMR (CDCl3, 376 MHz) –76.1 (d, J 
= 6.8 Hz); GC-MS (EI, m/z, 70 eV) 488 (24, M
+
), 397 (1), 333 (3), 241 (98), 236 (95), 
225 (4), 214 (7), 172 (5), 145 (38), 117 (24), 91 (100), 65 (12); Anal. Calcd. for 
C25H23F3N2O3S: C, 61.46; H, 4.75; N, 5.73. Found: C, 61.38; H, 4.82; N, 5.70. 
 
N-[3-{5-bromo-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfona
mide (3d)  
White solid; yield 99 %; mp: 140.7–141.7 °C; IR (KBr) 3405, 3279, 2923, 1598, 1462, 
1429, 1331, 1270, 1177, 1161, 1092, 948, 795, 668, 576 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) 8.04 (s, 1H), 7.50–7.40 (m, 3H), 7.29–7.24 (m, 1H), 7.19–7.14 (m, 1H), 
7.07–7.03 (m, 3H), 4.86–4.73 (m, 1H), 4.22–4.09 (m, 1H), 3.19 (d, J = 15.1, 4.1 Hz, 
1H), 2.95–2.87 (m, 1H), 2.34 (s, 3H); 13C NMR (CDCl3/CD3OD = 4/1, 101 MHz) 
143.4, 136.0, 134.8, 129.2, 128.4, 126.3, 125.4, 124.8, 124.6 (q, J = 282.6 Hz), 120.4, 
112.84, 112.82, 107.3, 55.0 (q, J = 30.3 Hz), 24.5, 21.5; 
19
F NMR (CDCl3, 376 MHz) 
–76.3 (d, J = 5.3 Hz); GC-MS (EI, m/z, 70 eV) 462 (8, M+[81Br]), 460 (8 ,M+[79Br]), 
291 (3), 289 (3), 210 (96), 208 (100), 154 (5), 129 (29), 102 (8), 91 (19), 65 (5); HRMS 
(FAB, m/z) Calcd. for C18H16BrF3N2O2S: 460.0068; Found: 460.0070.  
 
N-[3-{5-methoxycarbonyl-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenze
nesulfonamide (3e) 
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White solid; yield 94 %; mp: 146.0–146.7 °C; IR (KBr) 3292, 2958, 1694, 1620, 1437, 
1364, 1269, 1174, 943, 773, 701, 576 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 8.25 (s, 1H), 
8.16 (s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 7.9 Hz, 2H), 7.27 (d, J = 7.8 Hz, 1H), 
7.12 (s, 1H), 6.93 (d, J = 7.9 Hz, 2H), 5.23 (d, J = 7.7 Hz, 1H), 4.28–4.11 (m, 1H), 3.96 
(s, 3H), 3.27 (dd, J = 15.0, 3.7 Hz, 1H), 2.94 (dd, J = 15.0, 9.8 Hz, 1H), 2.29 (s, 3H); 
13
C NMR (CDCl3/CD3OD = 4/1, 101 MHz) 168.6, 142.4, 138.8, 137.0, 128.5, 126.2, 
125.5, 125.3, 124.6 (q, J = 282.6 Hz), 122.5, 120.6, 120.4, 110.9, 109.3, 55.7 (q, J = 
30.4 Hz), 51.6, 23.9, 20.9; 
19
F NMR (CDCl3, 376 MHz) –76.6 (d, J = 6.8 Hz); 
GC-MS (EI, m/z, 70 eV) 440 (6, M
+
), 409 (3), 269 (3), 188 (100), 156 (3), 129 (12), 91 
(9); Anal. Calcd. for C20H19F3N2O4S: C, 54.54; H, 4.35; N, 6.36. Found: C, 54.70; H, 
4.27; N, 6.35. 
 
N-[3-{5-cyano-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfonam
ide (3f) 
White solid; yield 76 %; mp: 181.0–183.0 °C; IR (KBr) 3261, 2923, 2224, 1736, 1620, 
1471, 1330, 1272, 1177, 1126, 947, 808, 675, 571 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 
8.37 (s, 1H), 7.72 (s, 1H), 7.53 (d, J = 6.8 Hz, 2H), 7.44 (d, J = 8.4 Hz, 1H), 7.38 (d, J 
= 8.4 Hz, 1H), 7.26 (s, 1H), 7.14 (d, J = 6.8 Hz, 2H), 4.79 (d, J = 9.4 Hz, 1H), 
4.28–4.17 (m, 1H), 3.25 (d, J = 15.1, 4.3 Hz, 1H), 3.01 (d, J = 15.1, 8.1 Hz, 1H), 2.38 (s, 
3H); 
13
C NMR (CDCl3/CD3OD = 4/1, 101 MHz) 142.6, 137.9, 137.3, 128.8, 126.6, 
126.2, 125.7, 124.6 (q, J = 282.6 Hz), 124.0, 123.5, 120.7, 112.1, 109.0, 101.2, 55.7 (q, 
J = 30.3 Hz), 24.1, 21.1; 
19
F NMR (CDCl3, 376 MHz) –76.5 (d, J = 6.8 Hz); GC-MS 
(EI, m/z, 70 eV) 407 (8, M
+
), 236 (5), 155 (100), 128 (3), 91 (10), 65 (3); HRMS (FAB, 
m/z) Calcd. for C19H16F3N3O2S: 407.0915; Found: 407.0901. 
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N-[3-{4-methoxy-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfon
amide (3g) 
White solid; yield 99 %; mp: 69.5–70.9 °C; IR (KBr) 3407, 3277, 2936, 1590, 1509, 
1340, 1272, 1174, 1126, 1090, 946, 810, 734, 668, 571 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) 7.83 (s, 1H), 7.09 (d, J = 7.2 Hz, 2H), 7.05 (t, J = 7.9 Hz, 1H), 6.82 (d, J = 7.9 
Hz, 1H), 6.82–6.72 (m, 3H), 6.45 (d, J = 7.9 Hz, 1H), 6.05 (d, J = 6.7 Hz, 1H), 
4.15–3.99 (m, 1H), 3.96 (s, 3H), 3.22 (dd, J = 14.1, 2.6 Hz, 1H), 3.06–2.97 (m 1H), 2.22 
(s, 3H); 
13
C NMR (CDCl3, 101 MHz) 153.0, 142.4, 137.9, 136.1, 128.5, 125.6, 124.8 
(q, J = 282.6 Hz), 122.8, 122.5, 116.9, 108.4, 105.2, 99.8, 55.4 (q, J = 29.6 Hz), 55.2, 
25.0, 21.4; 
19
F NMR (CDCl3, 376 MHz) –77.5 (d, J = 6.8 Hz); GC-MS (EI, m/z, 70 
eV) 412 (18, M
+
), 241 (2), 160 (100), 130 (21), 117 (5), 91 (10), 65 (3); HRMS (FAB, 
m/z) Calcd. for C19H19F3N2O3S: 412.1068; Found: 412.1068.  
 
N-[3-{4-tert-butyldimethylsilyloxy-(1H-indol-3-yl)}-1,1,1-trifluoropropan-2-yl]-4-meth
ylbenzenesulfonamide (3h) 
White solid; yield 99 %; mp: 65.0–67.0 °C; IR (KBr) 3400, 3257, 2932, 2860, 1580, 
1504, 1340, 1174, 943, 862, 671 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 7.81 (s, 1H), 7.05 
(d, J = 7.8 Hz, 2H), 6.95 (t, J = 8.0 Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.75 (s, 1H), 6.71 
(d, J = 7.2 Hz, 2H), 6.48 (d, J = 8.0 Hz, 1H), 6.26 (d, J = 6.4 Hz, 1H), 4.00–3.89 (m, 
1H), 3.23–3.10 (m, 2H), 2.24 (s, 3H), 1.03 (s, 9H), 0.396 (s, 3H), 0.356 (s, 3H); 13C 
NMR (CDCl3, 101 MHz) 148.7, 142.2, 138.4, 136.1, 128.5, 125.4, 124.8 (q, J = 282.6 
Hz), 122.5, 122.3, 118.9, 108.6, 108.1, 105.4, 58.1 (q, J = 29.6 Hz), 26.2, 24.2, 21.3, 
18.9, –3.34, –3.86; 19F NMR (CDCl3, 376 MHz) –77.0 (d, J = 6.8 Hz); GC-MS (EI, 
m/z, 70 eV) 512 (28, M
+
), 455 (100), 300 (32), 260 (55), 222 (36), 188 (19), 91 (26), 73 
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(16); Anal. Calcd. for C24H31F3N2O3SSi: C, 56.23; H, 6.09; N, 5.46. Found: C, 55.95; H, 
6.14; N, 5.45.  
 
N-[3-(2-phenyl-1H-indol-3-yl)-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfonami
de (3j) 
White solid; yield 97 %; mp: 180.0–181.5 °C; IR (KBr) 3415, 3274, 3056, 1598, 1491, 
1325, 1296, 1181, 1156, 1124, 955, 740, 665, 571, 547 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) 7.88 (s, 1H), 7.55–7.40 (m, 4H), 7.36 (d, J = 7.2 Hz, 2H), 7.27–7.13 (m, 5H), 
6.86 (d, J = 8.0 Hz, 2H), 4.37 (d, J = 8.6 Hz, 1H), 4.23–4.11 (m, 1H), 3.37 (dd, J = 14.9, 
3.7 Hz, 1H), 3.08 (dd, J = 14.9, 10.8 Hz, 1H), 2.31 (s, 3H); 
13
C NMR (CDCl3/CD3OD = 
4/1, 101 MHz) 142.3, 136.9, 135.8, 135.7, 132.5, 128.5, 128.1, 127.8, 127.6, 125.3, 
124.6 (q, J = 282.7 Hz), 121.6, 119.2, 117.6, 110.91, 110.86, 104.8, 55.4 (q, J = 30.0 
Hz), 23.7, 20.9; 
19
F NMR (CDCl3, 376 MHz) –77.2 (d, J = 6.0 Hz); GC-MS (EI, m/z, 
70 eV) 458 (2, M
+
), 302 (1), 206 (100), 178 (8), 155 (2), 128 (2), 91 (5); HRMS (FAB, 
m/z) Calcd. for C24H21F3N2O2S: 458.1276; Found: 458.1294. 
 
N-[3-(2-methyl-1H-indol-3-yl)-1,1,1-trifluoropropan-2-yl]-4-methylbenzenesulfonami
de (3k) 
White solid; yield 99 %; mp: 177.5–178.0 °C; IR (KBr) 3416, 3272, 2921, 1596, 1464, 
1330, 1246, 1178, 1126, 956, 805, 746, 690 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) 7.64 (s, 
1H), 7.36–7.29 (m, 3H), 7.17 (d, J = 8.0 Hz, 1H), 7.14–7.03 (m, 2H), 6.97 (d, J = 7.8 
Hz, 2H), 4.80 (d, J = 9.0 Hz, 1H), 4.22–4.08 (m, 1H), 3.18 (dd, J = 15.0, 4.5 Hz, 1H), 
2.91 (dd, J = 15.0, 8.4 Hz, 1H), 2.33 (s, 3H), 2.26 (s, 3H); 
13
C NMR (CDCl3/CD3OD = 
4/1, 101 MHz)142.5, 137.1, 135.2, 132.9, 128.7, 127.8, 125.6, 124.7 (q, J = 283.3 
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Hz), 120.5, 118.8, 116.6, 110.2, 103.8, 55.5 (q, J = 28.8 Hz), 23.8, 21.0, 10.7; 
19
F NMR 
(CDCl3, 376 MHz) –76.6 (d, J = 6.8 Hz); GC-MS (EI, m/z, 70 eV) 396 (7, M
+
), 144 
(100), 115 (3), 91 (7), 77 (2), 65 (2); Anal. Calcd. for C19H19F3N2O2S: C, 57.57; H, 
4.83; N, 7.07. Found: C, 57.33; H, 4.81; N, 7.05. 
 
3-(1H-indol-3-yl)-1,1,1-trifluoropropan-2-amine (5a)
3c
 
White solid; yield 61 %; mp: 72.0–72.5 °C; 1H NMR (CDCl3, 400 MHz) 8.09 (s, 1H), 
7.61 (d, J = 7.6 Hz, 1H), 7.38 (d, J = 8.2 Hz, 1H), 7.26–7.20 (m, 1H), 7.15 (t, J = 7.6 Hz, 
1H), 7.13 (s, 1H), 3.67–3.53 (m, 1H), 3.28 (dd, J = 14.5, 3.1 Hz, 1H), 2.82 (dd, J = 14.5, 
10.2 Hz, 1H), 1.35 (bs, 2H); 
13
C NMR (CDCl3, 101 MHz)136.4, 127.1, 126.6 (q, J = 
280.8 Hz), 123.2, 122.3, 120.0, 118.5, 111.3, 110.5, 53.5 (q, J = 28.1 Hz), 26.1 (q, J = 
1.8 Hz); 
19
F NMR (CDCl3, 376 MHz) –79.5 (d. J = 8.1 Hz); GC-MS (EI, m/z, 70 eV)  
228 (16, M
+
), 158 (1), 130 (100), 103 (6), 77 (8). 
 
5.4.4. Crystal Data for 3a 
(C18H17F3N2O2S): M = 382.40, T = 113 K, triclinic, space group P-1, a = 9.074(2) Å, b 
= 9.836(2) Å, c = 11.599(3) Å,  = 70.045(12)˚,  = 68.705(11)˚, = 72.73(2)˚, V = 
888.9(3) Å
3
, Z = 2, Dcalc = 1.429 Mg m
-3
,  = 0.227 mm-1,  = 0.71075 Å, max = 
27.50°, 16726 measured reflection, 4053 independent reflections, 239 refined 
parameters, GOF = 1.070, R[F
2
 > 2(F2)] = 0.0339, wR(F2) = 0.0999. The intensity data 
were collected on a Rigaku Saturn724 diffractometer using multi-layer mirror 
monochromated Mo-K. The structure was solved by direct methods (SIR20081) and 
the non-hydrogen atoms were refined anisotropically by full-matrix least-squares 
procedures on F
2
 for all reductions (SHELXL97
2
). Hydrogen atoms were refined using 
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the riding model. CCDC-990028 contains the supplementary crystallographic data for 
this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_ 
request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting. The 
Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; 
fax: +44 1223 336033. 
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Chapter six 
Overall Conclusions  
 
 
 In conclusion, four new strategies for synthesis of fluorinated compounds are reported. 
Mizoroki-Heck reaction of (1-fluorovinyl)methyldiphenylsilane with various aryl 
iodides in good to high yields with excellent stereoselectivity.  The addition of 
Ag2CO3 and MS4Å is effective in this reaction (Scheme 1).  
 
SiPh2Me
F
+
SiPh2Me
FArcat. Pd(OAc)2, Ag2CO3 
1,4-dioxane, MS4Å, 90℃
ArI
up to 88%
14 examples  
Scheme 1. Mizoroki-Heck reaction of (1-fluorovinyl)methyldiphenylsilane 
 
The thiolate generated from thiol and sodium hydride in 1,4-dioxane reacted with 
2-bromo-3,3,3-trifluoro-1-propene at room temperature to afford the corresponding 
2-bromo-3,3-difluoroallyl sulphide as SN2’ product.  The generated corresponding 
product using benzyl thiol was treated by silyl chloride and LDA, through work-up and 
silica gel column produced 2-aryl-3-fluoro-5-silylthiophenes (Scheme 2). 
 
F3C
Br
ArCH2SH, NaH
1,4-dioxane, rt. Br
F2C
S Ar
LDA, R3SiCl
THF, -78℃
then work-up
silica gel column
S
F
ArR3Si
up to 89%
8 examples  
Scheme 2. Synthesis of 2-aryl-3-fluoro-5-silylthiophenes 
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The access to functionalized mono-fluorinated cyclopropanes and aziridines using 
(1-fluorovinyl)diphenylsulfonium salt was accomplished (Scheme 3). 
 
S+Ph2・TfO
-
F
+
EWG1
EWG2
DBU 
CH3CN, rt.
F
EWG2
EWG1
up to 98%
9 examples  
 Scheme 3. Synthesis of mono-fluorinated cyclopropanes 
 
Diethylzinc-promoted synthesis of CF3-containing tryptamine analogues from indoles 
and 2-CF3-N-Ts-aziridine was achieved.  CF3-containing tryptamines were prepared 
with perfect stereoselectivity and excellent yield in this reaction (Scheme 4). 
 
N
Ts
CF3
+
N
H
R
Et2Zn
toluene, 100℃
N
H
R
CF3
NHTs
up to 99%
10 examples  
Scheme 4. Synthesis of CF3-containing tryptamines 
 
The use of our new methods enables to synthesize some new partially fluorinated 
compounds.  These compounds may be useful candidates for bioactive molecules 
and/or functional materials. 
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